Capsule
Spring 2020
University of Maryland School of Pharmacy Magazine for Alumni and Friends
UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY TAKES LEAD IN EDUCATION, RESEARCH, PRACTICE, AND OUTREACH
IN THIS ISSUE:
FY ’18 Annual Report
DEAN’S MESSAGE
We all know someone. With an estimated 46.6 million Americans suffering from a mental illness, we all know someone. That someone might be a family member or a friend. It might be a co-worker. It could be the cashier at the grocery store we see each week. Or it could be ourselves. Whatever your relationship to mental illness, you surely know its impact. And the complex nature of the wide array of disorders classified as mental illness. During the last several decades, these disorders have moved out of the shadows, recognized as legitimate and complex medical conditions. The University of Maryland School of Pharmacy has long been supporting patients who suffer from mental health disorders. Some of our earliest work in this area began in the 1980s when the School received its first contract from the state of Maryland to administer the pharmacy program in the state’s mental health facilities. That program has expanded to include the School’s oldest pharmacy residency program and clinical sites for our faculty. The School also works with patients affected by substance abuse disorders, examines state and federal policies related to the prescribing of antipsychotic medications, and seeks to create new and improved treatment options for illnesses such as depression. And as an institution of higher learning, we educate our students — future health care professionals — on mental health disorders and the myriad treatment options that are available. We are now also paying closer attention to the mental health needs of our community — our faculty, staff, and students — encouraging them to speak up when they need help and continuing to connect them with assistance resources. This issue of Capsule details our work in this important area. It’s sobering to see it cataloged together in these pages. But it’s also inspiring to see all that we are doing to assist those who suffer and to reduce further suffering.
In the spirit of expertise, influence, and impact,
Natalie D. Eddington, PhD ’89, FAAPS, FCP Dean and Professor Executive Director, University Regional Partnerships
MISSION The University of Maryland School of Pharmacy leads pharmacy education, scientific discovery, patient care, and community engagement in the state of Maryland and beyond. VISION We will achieve our mission by: • inspiring excellence in our students through a contemporary curriculum, innovative educational experiences, and strategic professional relationships. • advancing scientific knowledge across the spectrum of drug discovery, health services, and practice based and translational research with significant focus on collaborative partnerships. • expanding the impact of the pharmacist’s role on direct patient care and health outcomes. • building and nurturing relationships with all members of our community. • capitalizing on our entrepreneurial spirit to improve pharmaceutical research, practice, and education in Maryland and throughout the world. PLEDGE We are proud to be critical thinkers, lifelong learners, and leaders who are sought for our expertise. We earn our reputation with the highest standards of personal ethics and professional conduct. Students and education are central to everything we do. We engage the community; together, we contribute to the improved health of society. We celebrate the distinctive talents of our faculty, staff, and students. We honor our traditions and advocate for dynamic changes in pharmacy practice, education, and research. We create the future of pharmacy.
Capsule Contents University of Maryland School of Pharmacy Alumni Magazine
Spring 2020 Becky Ceraul, Capsule Editor Assistant Dean, Communications and Marketing School of Pharmacy Chris Zang, Director, Editorial Services Julie Bower, Assistant Director, Design Services University of Maryland, Baltimore Office of Communications and Public Affairs Special thanks to the following contributors: Ken Boyden, JD, EdD Associate Dean Development and Alumni Affairs Malissa Carroll Web Content Specialist Greer Griffith Director Annual Giving and Alumni Affairs Erin Merino Senior Marketing Specialist Amanda Wolfe Digital Media Specialist School of Pharmacy Student Government Association
We welcome your comments, news, and suggestions for articles. Send your ideas to Becky Ceraul at the University of Maryland School of Pharmacy, 20 N. Pine St., Room N302, Baltimore, MD 21201. Email: rceraul@rx.umaryland.edu; Telephone: 410-706-1690; Fax: 410-706-4012. Copyright © 2020 University of Maryland School of Pharmacy
www.pharmacy.umaryland.edu
2
SCHOOL NEWS
8
COMMITTED TO WELL-BEING
15
FACULTY PROFILE
16
STAFF PROFILE
17 STUDENT NEWS 22 PRECEPTOR PROFILE 23 ALUMNI NEWS 27 ALUMNI PROFILE 29
DONOR PROFILE
30 RESIDENT PROFILE 31 ANNUAL REPORT Read More, See More, Share More! Read in-depth biographies of faculty, see additional pictures of School events, and share School news with your friends on social media. More details on the articles covered in this issue of Capsule are available in an electronic version — online. You can view Capsule from any mobile device. Visit www.pharmacy.umaryland. edu/capsule and start learning more about the University of Maryland School of Pharmacy.
SCHOOL NEWS
$2 Million Grant Investigates Diversity, Recruitment, and Retention in Aging Research
Daniel Mullins
Jay Magaziner
Daniel Mullins, PhD, professor and chair of the Department of Pharmaceutical Health Services Research (PHSR) at the School of Pharmacy, and Jay Magaziner, PhD, MSHyg, professor and chair of the Department of Epidemiology and Public Health at the University of Maryland School of Medicine, have been awarded a three-year, $2 million grant from the National Institute on Aging (NIA) to examine diversity, recruitment, and retention in aging research. They will lead a collaborative team that includes researchers, community members, and other stakeholders to develop evidence-based strategies that investigators can use to help recruit and retain older adults and diverse populations in research, and establish a registry of West Baltimore community members who are willing to participate in NIAfunded clinical research studies. “As co-principal investigators, Dr. Magaziner and I are excited to lead this stellar A-team collaboration that will help us determine the best strategies and methods for enhancing diversity in aging research,” says Mullins, who also serves as executive director of the Patient-Centered Involvement in Evaluating the Effectiveness of Treatments (PATIENTS) Program at the School of Pharmacy. “We want to facilitate effective bi-directional learning throughout this study, and learn from our community members what approaches they believe will work best in their communities, as well as have them learn from us about the importance of research and how participation can help them, their families, and their communities.” Research has demonstrated that medications, medical devices, and behavioral interventions can be made safer and
2
c a psu l e
www.pharmacy.umaryland.edu
more effective for all people when clinical studies include diverse populations. However, addressing the wide range of physical, socioeconomic, and other barriers that prevent individuals from aging populations, as well as underserved populations, from participating in these studies remains a challenge for many researchers. Building on the pioneering patient engagement efforts led by the PATIENTS Program and cutting-edge research conducted by faculty in the Center for Research on Aging at the School of Medicine, this project uses a collaborative team-based approach to address existing knowledge gaps and assess the effectiveness of strategies designed to increase diversity among older adult participants in clinical research studies. “Most medications and therapies are tested and brought to market based on studies conducted not only in younger people, but in a relatively homogeneous group of volunteers,” says Magaziner, who also serves as director of the Center for Research on Aging. “These are typically individuals who have never been diagnosed with a chronic illness and who are able to easily travel to and from the location where the study is being conducted, which is often not an accurate representation of the majority of people who will use these drugs in the real world.” He adds, “Fortunately, times are changing. There is now a big push to include not only older adults in research, but also individuals from more diverse populations. Thanks to the expertise of the PATIENTS Program and the Center for Research on Aging, we will be able to have an impact in this important area.” The study will use a mixed-methods approach that leverages both qualitative and quantitative methodologies to test and compare recruitment and retention strategies. It will primarily focus on three populations that are not often engaged in clinical research studies: older African-Americans, older adults with disabilities, and older adults who cannot leave their homes. The research team will be divided into three cores (Executive, Community and Collaboration, and Aging Research and Bioethics), as well as an External Advisory Board that will provide guidance and advice on the study. Researchers also will employ a process known as collaborative evaluation, which will engage community members and other stakeholders throughout the evaluation process. At the conclusion of the study, Mullins and Magaziner estimate that approximately 3,000 West Baltimore community members will have been recruited into the registry, giving their consent to be contacted to participate in future NIA-funded clinical research studies. b
School Mourns Passing of Two Retired Faculty Members The School of Pharmacy lost two dear former faculty members recently with the passing of Robert Michocki, PharmD ’75, BCPS, and Ralph Blomster, PhD. Michocki, alumnus and professor emeritus in the Department of Pharmacy Practice and Science (PPS), passed away on Oct. 15. “During his career at the School, Dr. Michocki impacted the lives of thousands of faculty, staff, and students,” says Natalie D. Eddington, PhD ’89, FAAPS, FCP, dean and professor of the School of Pharmacy. “His contributions to the School and the pharmacy Robert Michocki profession live on in the actions of our alumni, who so ably care for their patients, and in those faculty members who were fortunate to call him a colleague and who looked to him for mentorship and guidance.” Michocki first graduated from the School in 1971, and immediately joined the faculty. While on faculty, he once again became a student, pursuing his Doctor of Pharmacy (PharmD) in the School’s post-baccalaureate PharmD program — a program he helped launch. Michocki served the School as chair of PPS from April 2003 to August 2006, as well as interim chair from July 1991 to September 1992, and January 1996 to July 1997. He maintained practice sites in internal medicine, geriatrics, and emergency medicine, as well as a long-running family medicine practice site at the University of Maryland Medical Center. He also had a 35-year career as a consultant at the Baltimore Veterans Affairs Medical Center. Throughout his career, Michocki gave numerous presentations at professional conferences, published in peerreviewed journals, authored book chapters, and co-authored a book on drug use patterns. He retired from the School of Pharmacy in 2014, after 43 years of service. “Dr. Michocki relished the time he spent with students, learning just as much from them as they learned from him,” says Eddington. “So strong was his connection to our pharmacy students that he was the School’s Teacher of the Year a recordbreaking 10 times.” Michocki’s impact as an educator was not only felt at the School of Pharmacy, but across the University of Maryland, Baltimore campus. In 2011, the Department of Family and Community Medicine at the University of Maryland School of Medicine honored him with its Excellence in Teaching Award. He also was named the School of Pharmacy’s Evander Frank Kelly Honored Alumnus in 2003. b
Blomster, professor emeritus in the Department of Pharmaceutical Sciences, passed away on Jan. 27. “Dr. Blomster’s presence had an indelible impact on all of us at the School of Pharmacy,” says Natalie D. Eddington, PhD ’89, FAAPS, FCP, dean and professor of the School. “He championed the cutting-edge research conducted by our faculty and was committed to ensuring a superior Ralph Blomster education for all of our students, always welcoming an opportunity to share his knowledge and expertise with them. With his recent passing, we have lost not only a caring colleague and great scientific mind, but also a beloved friend. Our thoughts are with his family during this difficult time.” After receiving his doctorate in pharmacognosy — the study of plants and other natural resources as a potential source for medicinal drugs — Blomster joined the faculty of the School’s former Department of Pharmacognosy, serving as professor and chair of the department from 1968 to 1979. During that time, he journeyed to numerous South American countries, including Peru, Bolivia, and Brazil, where he spoke with traditional healers and collected samples of the plants they used to treat various illnesses. At the School, Blomster and his graduate students worked to isolate the active compounds in those plants, developing an anti-inflammatory compound and a wound-healing agent that were sold in Europe. Blomster continued to serve as chair of the renamed Department of Medicinal Chemistry/Pharmacognosy until 1989. During his tenure, Blomster diligently worked to increase the number of faculty members in the department, which grew from 15 in 1968 to 50 in 1996, as well as enhance research, graduate education, and funding within the department. But it was in his teaching and mentoring that Blomster truly shined. A passionate educator, Blomster delivered enthusiastic lectures sprinkled with humorous anecdotes to keep his students engaged. He also took time to mentor junior faculty members. “He gave us advice, showed us the ropes, and helped us succeed,” says Alexander MacKerell Jr., PhD, the GrollmanGlick Professor of Pharmaceutical Sciences and director of the School’s Computer-Aided Drug Design Center. Blomster retired from the School in 1996. b sp r i ng 2 0 2 0
3
SCHOOL NEWS
SOP Collaborates with emocha to Offer Comprehensive Clinical Adherence Solution The Center for Innovative Pharmacy Solutions (CIPS) at the School of Pharmacy is collaborating with emocha Mobile Health to expand the company’s clinician-led adherence solution offering. Through this collaboration, pharmacists in the School’s e-Health Center will provide patients with comprehensive medication review and reconciliation services through a mobile application that protects their privacy. emocha will offer this service to hospitals, health systems, and health insurers, with the goal to increase medication adherence, address medication-related problems, and manage the rising cost of care and readmission rates. “We are excited to collaborate with this outstanding institution that has a strong track record of developing technology-enabled services to maximize patient engagement and improve adherence,” says Sebastian Seiguer, JD, MBA, who is CEO at emocha. “By leveraging the University of Maryland School of Pharmacy’s e-Health Center and expertise, we are able to provide the highest quality medication review to patients and have expanded our ability to rapidly address medication-related problems.” It has been estimated that medication nonadherence costs U.S. health systems and payers between $100 billion and $289 billion annually in preventable hospitalizations, while resulting in poor health outcomes. Adverse drug events in the U.S. cause more than 1 million visits to emergency departments and approximately 350,000 hospitalizations annually. Through emocha, patients improve medication adherence with video Directly Observed Therapy (DOT) and a clinician-led support team. DOT is the gold standard for medication adherence, and emocha is the market leader in video DOT, with more than 70 customers and multiple independent studies validating greater than 90 percent adherence rates. Patients enrolled in emocha’s video DOT programs use a Health Insurance Portability and Accountability Act (HIPAA) compliant mobile app to video-record themselves taking their medications while working with emocha nurses and health care workers. Patients can report side effects, access local resources, receive medication reminders, and track their
4
c a psu l e
www.pharmacy.umaryland.edu
treatment progress. This collaboration with the School of Pharmacy expands emocha’s solution to add optimization of medication regimens offered by the medication experts — pharmacists in the School’s e-Health Center. In addition to behavioral factors, a significant barrier to adherence includes medication problems ranging from improper drug administration to incorrect dosage. The collaboration between emocha and the School of Pharmacy’s CIPS will facilitate the management of medication-related problems that impact adherence. “Incorporating pharmacists who work in the School’s e-Health Center into the emocha program to confirm that patients follow correct technique, and to provide timely interventions to solve drug-related problems such as side effects and maximize therapeutic outcome, makes emocha the most comprehensive solution to medication nonadherence in the world,” Seiguer says. “At the University of Maryland School of Pharmacy, we focus on providing highly supportive services to patients through comprehensive medication review and reconciliation to prevent and reduce drug-related problems,” says Magaly Rodriguez de Bittner, PharmD ’83, BCPS, CDE, FAPhA, director of CIPS and associate dean for clinical services and practice transformation at the School. “emocha is leading the way on the development of health-related technologies, and we are pleased to collaborate with them to provide medication therapy management services to a wide array of patients using this technology.” “The Center for Innovative Pharmacy Solutions’ collaboration with emocha truly demonstrates the School’s Pharmapreneurship™ initiative in action and is characterized by leadership, expertise, and new venture design,” says Natalie D. Eddington, PhD ’89, FAAPS, FCP, dean and professor of the School. “By collaborating with a technology startup company in Baltimore City to deliver medication therapy management services to patients, CIPS is meeting a market need, with the ultimate goal of improving patient outcomes, reducing health care costs, and reducing hospital readmission rates.” b
$1.6 Million Grant Examines Impact of Antipsychotic Drug Reductions in Long-Term Care Facilities Linda Wastila, PhD, BSPharm, MSPH, the Parke-Davis Chair of Geriatric Pharmacotherapy in the Department of Pharmaceutical Health Services Research, has received a three-year, $1.6 million grant from the National Institutes of Health to investigate how a recent nationwide initiative to reduce the use of antipsychotic medications among older Linda Wastila adults in long-term care facilities has impacted the use of other medications at those facilities, as well as patient health outcomes. “The organizations involved in this initiative have done an excellent job reporting the reductions in the use of antipsychotics, but our team will be the first to examine how efforts to reduce the use of this class of medications impacts the use of other medications and health outcomes for older adults in long-term care facilities,” says Wastila, who also serves as the director of research for the Peter Lamy Center on Drug Therapy and Aging at the School. Antipsychotics are a class of medications primarily used to manage symptoms associated with psychosis, including delusions, hallucinations, and paranoia. While these medications are typically used to treat patients diagnosed with conditions such as schizophrenia and bipolar disorder, some health care professionals also prescribe them to patients diagnosed with Alzheimer’s disease and other related dementias. Prolonged use of these medications is associated with a number of adverse effects, which can be particularly detrimental for older adults. The national initiative leading the effort to reduce the use of antipsychotic medications among older adults in long-term care facilities is known as the National Partnership to Improve Dementia Care. It is a private-public coalition established in 2012 that includes the Centers for Medicare and Medicaid Services (CMS), consumers, advocacy organizations, health care providers, and professional associations. Within five years of its launch, the initiative saw a 34.1 percent reduction in the use of antipsychotics across all long-term care facility residents, to a national annual prevalence of 15.7 percent – a number that continues to decrease each year.
“We absolutely believe that antipsychotics have been overused in the general population, as well as in long-term care facilities,” confirms Wastila. “But we are also concerned about the inadvertent, but very real, impact that a policy such as this might have when the only goal is to reduce the use of these medications by a certain percentage. Were these patients switched to other medications? What impact might those medication changes have had on patients?” For Wastila, this study represents a continuation of her well-recognized work examining drug use among older adults. She and her team will use advanced methodological approaches and comprehensive national data — including a nationally representative, 100 percent sample of Medicare beneficiaries who resided in long-term care facilities from 2010 to 2016 — to assess state-, facility-, and individual-level characteristics that might have mediated the impacts of the nationwide initiative that affected more than 1.4 million longterm care facility residents. The team will focus on residents with Alzheimer’s disease and related dementias to assess the initiative’s impact on changes in the use of antipsychotics; potentially harmful use of other psychopharmacological medications, such as opioids, antidepressants, and anticonvulsants; and selected public health and individual patient health outcomes. “One element of this study that really excites our team is that we have the opportunity to build a close-to-100 percent sample of all Medicare beneficiaries who resided in long-term care facilities for an extended period of time,” says Wastila. “Oftentimes, the sample sizes used in studies such as this one are too small to allow us to see what is going on at the facility level. For this study, we can look at all of the patients in all of the facilities that receive funding from Medicare – that is approximately 90 to 95 percent of all long-term care facilities in the nation.” She adds, “It also allows us to look at how facility characteristics — such as size, profit status, and staffing patterns — influence antipsychotic and other medication use and outcomes.” The ultimate goal of the research is to provide guidance to health care providers and policymakers on how to optimize prescribing decisions for older patients in long-term care facilities. b
sp r i ng 2 0 2 0
5
SCHOOL NEWS
Palliative Care Program Celebrates First Convocation Faculty and staff from the School of Pharmacy joined family and friends on Aug. 16 to celebrate the first graduating class of the online Master of Science (MS) and Graduate Certificates in Palliative Care program. “I am incredibly proud and excited to host the first graduation celebration for our online MS and Graduate Certificates in Palliative Care program,” said Mary Lynn McPherson, PharmD ’86, MA, MDE, BCPS, CPE, professor and executive director for advanced postgraduate education in palliative care in the Department of Pharmacy Practice and Science (PPS) at the School of Pharmacy. “While all of the students in our program are amazing, this first cohort holds a special place in my heart.” The ceremony began with remarks from Jill A. Morgan, PharmD, BCPS, BCPPS, professor and chair of PPS at the School of Pharmacy, and Mary Jo Bondy, DHEd, MSH, PA-C, assistant dean of graduate academic programs at the University of Maryland, Baltimore (UMB) Graduate School, who assured graduates that they have been provided with the knowledge and skills necessary to lead the development of palliative care and hospice services at their workplaces and encouraged them to take the next step in advancing their careers. “Earning your master’s degree or graduate certificate in palliative care now positions you to make an incredible impact in your field,” Morgan said. “You have been well-prepared to engage more deeply and fully in your careers — caring for your patients, developing hospice or palliative care programs, earning promotions, or specializing in a specific area within palliative care. I encourage you all to go out and take great care of your patients and the profession. Truly, there is no limit to what you can achieve.” “UMB is on a mission to solve real-world problems,” added Bondy. “Through your education and training, you are now uniquely prepared to help us fulfill this mission. With your expert understanding of the social, spiritual, and health care needs of patients dealing with chronic and end-of-life illness, you are well-equipped to guide and lead the delivery of care for this vulnerable population.” Martha Martin, MD, MS ’19, consulting psychiatrist at
Millie Whyte, MS ’19, is hooded by Jill Morgan, professor and chair of the Department of Pharmacy Practice and Science (PPS), and Cherokee Layson-Wolf, associate dean for student affairs and associate professor.
Montgomery Hospice, delivered the message from the class. She emphasized how the numerous unique features of the two-year program, including its flexible format, interdisciplinary coursework, and emphasis on student creativity, came together to foster an experience for students that not only facilitated professional learning, but also personal growth. “We have been challenged, but it has been the best kind of challenge,” Martin said. “We had the extraordinary privilege of being taught by all of the pioneers in this developing field — luminaries lighting the path for us as we join the ranks of professionals dedicating our lives to this burgeoning field. We are now all a part of something far greater than ourselves, and we too are contributing to the richness of the future.” Established in 2017, the online MS and Graduate Certificates in Palliative Care program addresses the growing need for interprofessional education across the fields of hospice and palliative care. The program is well-suited for a wide range of professionals, including physicians, pharmacists, thanatologists, nurses, advanced practice nurses, physician assistants, psychologists, social workers, chaplains, and administrators. It is designed for any professional who currently works or wishes to work in hospice and palliative care, and who wants to gain a deeper understanding of the field. b
The MS and Graduate Certificates in Palliative Care Class of 2019 with Mary Lynn McPherson (right), professor of pharmacy practice and science and executive director for advanced postgraduate education in palliative care. 6
p su l e c a psu
www.pharmacy.umaryland.edu www.pharmacy.umaryland.edu
Laurels The following School of Pharmacy staff members have been accepted into the University of Maryland, Baltimore’s (UMB) Emerging Leaders Program for the 2019-2020 academic year: • Malissa Carroll – Office of Communications and Marketing • Nicole Derr – Dean’s Office • Shardai Jones – Department of Pharmaceutical Health Services Research • Erin Merino – Office of Communications and Marketing • Kristina San Juan – Department of Pharmaceutical Sciences Nicole Brandt, PharmD ’97, MBA, BCPP, CGP, FASCP; Joshua Chou, PharmD ’17; and Barbara Zarowitz, PharmD, received the Top Poster Award at the 2019 Annual Meeting of the American Society of Consultant Pharmacists in Texas in November. Kimberly Claeys, PharmD, has been named a 2019 Outstanding Reviewer by the journal Pharmacotherapy. Andrew Coop, PhD, has been named the 2019 Maryland Chemist of the Year by the Maryland Section of the American Chemical Society. He also has been appointed to two American Association of Colleges of Pharmacy (AACP) committees: the Council of
Sections’ Strategic Planning Committee and the Volwiler Research Achievement Award Committee. Bethany DiPaula, PharmD '95, has been appointed to the American Society of Health-System Pharmacists’ Opioid Taskforce. Alison Duffy, PharmD, received the Maryland Society of Health-System Pharmacy’s (MSHP) Excellence Award. Agnes Ann Feemster, PharmD, received MSHP’s Medication Safety Award. Joga Gobburu, PhD, MBA, has been named a fellow of the American Association of Pharmaceutical Scientists. Mojdeh Heavner, PharmD ’08, BCPS, BCCCP, has been named a fellow of the American College of Critical Care Medicine. Jace Jones, PhD, has received a 2020 New Investigator Award from AACP. Lisa Lebovitz, JD, has been appointed to the AACP’s Pharmacy College Admissions Test Advisory Committee and to UMB’s President’s Council for Women. James Leonard, PharmD, a poison specialist at the Maryland Poison Center, has been named a diplomate of the American Board of Applied Toxicology.
Alexander MacKerell Jr., PhD, received a U.S. patent for “Inhibitors of the Notch Transcriptional Activation Complex and Methods of Use of the Same.” Mary Lynn McPherson, PharmD ’86, MA, MDE, BCPS, CPE, has been appointed to the Board of Directors of the American Association of Hospice and Palliative Medicine, the first non-physician appointee. She also has been named co-chair of the 2020 International Conference on Opioids. Ebere Onukwugha, PhD, has been appointed to the state of Maryland’s Prescription Drug Affordability Board. James Polli, PhD, has been elected president of the Association of Graduate Regulatory Educators. Brent Reed, PharmD, has been named a fellow of the American College of Clinical Pharmacy. Kristin Watson, PharmD, has been appointed to the Maryland State Advisory Council on Health and Wellness.
The following School of Pharmacy faculty received promotions: Peter Doshi, PhD – assistant professor of pharmaceutical health services research (PHSR) to associate professor with tenure Agnes Ann Feemster, PharmD – assistant professor of pharmacy practice and science (PPS) to associate professor Emily Heil, PharmD – assistant professor of PPS to associate professor Lisa Jones, PhD –assistant professor of pharmaceutical sciences (PSC) to associate professor with tenure Joey Mattingly, PharmD, PhD – assistant professor of PPS to associate professor of PHSR Kathleen Pincus, PharmD ’09 – assistant professor of PPS to associate professor Jana Shen, PhD – associate professor of PSC with tenure to professor with tenure
Angela Wilks, PhD, has been named chair of the National Institutes of Health’s Prokaryotic Cell and Molecular Biology Study Section for a two-year term.
sp r i ng 2 0 2 0
7
8
c a p su l e
www.pharmacy.umaryland.edu
COMMITTED TO WELL-BEING The School of Pharmacy takes innovative approaches to mental health By Christianna McCausland
Mental illnesses are common in the United States. According to the National Institute of Mental Health (NIMH), in 2017 there were an estimated 46.6 million adults aged 18 or older with any mental illness (AMI), and 11.2 million with serious mental illness (SMI) wherein the mental, behavioral, or emotional disorder results in serious functional impairment. While these numbers are high, treatment still lags. NIMH reports that 42.6 percent of those with AMI and 66.7 percent of those with SMI received mental health services within the last year of the reporting. Alarmingly, the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics indicates that rates of suicide in the United States have steadily risen in recent years, up 33 percent from 1999 to 2017. “The University of Maryland School of Pharmacy has world-renowned experts in the area of mental health, which puts us in a leadership role nationally in terms of education in the areas of mental health,” says Natalie D. Eddington, PhD '89, FAAPS, FCP, dean and professor. “Our School has always seen mental health as a primary focus of the overall health of patients.”
sp r i ng 2 0 2 0
9
The prevalence of mental health issues is hitting close to home, too. In the pharmacy profession specifically, there is a new awareness of the mental health of practitioners and the need to safeguard against burnout. Noting that a survey of health system pharmacists published in 2018 indicated that 53 percent of respondents reported a high degree of burnout, the American Society of Health-System Pharmacists (ASHP) launched a series of efforts and online tools to foster well-being among its members. Similarly, the American Pharmacists Association (APhA) announced the creation of the Well-Being Index, a screening tool to evaluate fatigue, depression, burnout, anxiety/stress, and mental/physical quality of life. It is just one of APhA’s many efforts to improve the well-being and resiliency of pharmacists and pharmacy personnel. “There have been so many changes in the work environment that impact pharmacist wellbeing, and the well-being of the provider is so important to offering the best care for the patient,” says Cherokee Layson-Wolf, PharmD '00, CGP, BCACP, FAPhA, associate professor in the Department of Pharmacy Practice and Science (PPS) and associate dean for Cherokee Layson-Wolf student affairs. “Our students get exposure to the pharmacists’ experience through their rotations and learn how to have conversations about [mental health].” There has never been a more pressing time for the School to continue its role as a leader in mental health education, research, practice, and outreach.
The Mental Health Program
Perhaps the School’s most notable contribution to improving access to mental health care is its Mental Health Program (MHP). Raymond Love, PharmD ’77, BCPP, FASHP, professor in PPS and director of MHP, recalls the early 1980s, when several of the state of Maryland’s psychiatric and developmental disability facilities were in danger of losing their federal funding due to poor practices in prescribing, dispensing, and monitoring of psychiatric medicines. At the time, Love was director of pharmacy at a facility in Cumberland, Md., and an adjunct faculty member at the School of Pharmacy. Together with William J. Kinnard, PhD, then dean of the School, and the Maryland Department of Health, a memorandum of understanding was created in 1986 for the School
10
c a p su l e
www.pharmacy.umaryland.edu
to provide clinical and administrative pharmacy services at three state facilities. “We discovered a lack of coordination among the state facilities in terms of formulary and drug use policies, so we moved to a centralized Pharmacy and Therapeutics Committee for the facilities,” says Love. “Once we came in and developed a plan, we were able to turn things around pretty quickly.” Today, MHP provides services at all five of the state’s adult psychiatric facilities and employs nearly 50 faculty and staff throughout Maryland. MHP’s Raymond Love multiplicity of efforts has introduced innovations into the statewide system including group purchasing programs, dose optimization, coordinated on-call services, and statewide data tracking. It has participated in several research grants and assisted the state with bioterrorism initiatives related to anthrax. Love explains that the success of MHP and its rapid expansion is rooted in its philosophy that rather than simply fixing a problem, MHP gets to the root of what is causing the issue and builds a solution. For example, MHP did not just fix the state hospital formulary — it examined why there was a problem, articulated a fix, then staffed the solution with the best people. “Sometimes people ask us a question, but don’t understand what they really need,” says Love. “We help people not only address their problems, we help them build systems.” Brian Hepburn, MD, executive director of the National Association of State Mental Health Program Directors, worked with MHP in his capacity as medical director for the Mental Hygiene Administration and as the state’s commissioner of mental health, a position he held from 2002 to 2015. He says the contributions made by the School of Pharmacy generally and Love specifically through MHP cannot be overstated. “The School’s MHP is one of the best I’ve ever seen and without a doubt has improved quality across all the state hospitals,” he states. “And they work closely with medical personnel in the hospitals, so the impact goes beyond the pharmacist.”
Leading at Midtown
One of MHP’s newest programs is located in the psychiatric unit at the University of Maryland Midtown campus, where Megan Ehret, PharmD, associate professor in PPS, is the advanced practice pharmacist. Ehret’s position is so new she’s still evolving her role — the inpatient unit just underwent a complete renovation and the
partial hospitalization unit at Midtown only opened last year. Ehret is a member of the treatment team and also is active in training medical students. “The pharmacists here [at Midtown] felt that they were going to be asked to provide more services in psychiatry, and they didn’t feel they had the expertise,” Ehret explains. “They reached out to the School for help evaluating what services are needed and to help train their pharmacists to provide those services.” In addition to her work on inpatient rounding, Ehret has been instrumental in increasing Megan Ehret access to long-acting injectable antipsychotics to patients in need upon their discharge from the hospital. She also is helping the hospital write its policies and procedures for the use of esketamine nasal spray for treatment-resistant depression. Perhaps the most rewarding part of her job is working with trainees. “Residents and students fresh into this are so eager to learn and be advocates for the patients, which is an important quality in a care provider,” says Ehret. She continues that mental health patients rarely go from unwell to “cured,” and frequently return for services over the life span. “It’s so important to understand this is a returning [patient] population, that we can’t be frustrated by that, and for us to determine how we can best treat them.”
Care for the Developmentally Disabled
Jason Noel, PharmD, associate professor in PPS, also works with a returning patient population through his work in the Mental Health Program. Noel is a pharmacist who practices with the Maryland Developmental Disabilities Administration (DDA), a division of the state Department of Health that cares for more than 16,000 Marylanders with intellectual and developmental disabilities who receive services through a federally funded waiver administered by Medicaid. According to Noel, “These individuals often present with multiple limitations in intellectual and social functioning and have complex medical issues such as seizure disorders that require medical and pharmaceutical attention.” Noel takes referrals from community provider agencies of individuals deemed eligible through DDA for him to review their medications and make recommendations. Additionally, Noel
participates in a weekly interdisciplinary clinic at the residential Potomac Center in Hagerstown, Md., reviewing psychotropic medications, patient responses to those medications, and adjusting treatment as needed. He also works on site at the Secure Evaluation and Therapeutic Treatment (SETT) program on the campus of Springfield Hospital Center in Sykesville, Md., where those with intellectual disabilities who have been involved in a crime undergo assessments of competency to stand trial. Noel explains that while his are some of the most complex patients, access to clinical expertise and different treatment approaches combined with a commitment to not only stabilize patients but also replace self-injurious or difficult behaviors with adaptive behaviors has resulted in success. He’s seen patients who couldn’t leave the house for work become engaged in daily activities and others who have failed multiple community placements find stable Jason Noel residential life. “In my work we follow people over longer periods of time rather than in an acute psychiatric setting, so we get to see progress,” he says. “There’s not always a straight line from being in crisis to being well, but we are able to see, over a period of time, very dramatic improvements and successes.”
Training the Next Generation of Practitioners
Noel is not only a member of MHP, he is also a graduate of its residency program. Begun in 1987, the ASHP-accredited Psychiatric Pharmacy Practice Residency was the School of Pharmacy’s first residency program. The program is now overseen by another graduate, Bethany DiPaula, PharmD ’95, BCPP, professor in PPS and residency director. The program has trained 34 residents since it began, many of whom go on to leadership positions in pharmacy practice and/or as faculty. Many trainees are retained by the School, thus expanding psychiatric pharmacy services at the University of Maryland, Baltimore. “We currently have eight board-certified psychiatric pharmacy preceptors associated with our residency program,” says DiPaula. “Ours is a much larger program than many out there and gives our residents the opportunity to train under psychiatric pharmacists.” DiPaula’s own work has made important inroads in the treatment
sp ring 2 0 2 0
11
SPOTLIGHT ON RESEARCH A Fast-Acting Antidepressant The National Institute of Mental Health (NIMH) cites depression as the most common mental disorder in the United States. Selective serotonin reuptake inhibitor (SSRI) medications revolutionized treatment for depression, changing the lives of innumerable individuals when they were introduced in the late 1980s. However, SSRIs do not work for everyone and, more importantly, there is a latency before efficacy is evident, which can be two to four weeks. “Because SSRIs take a long time to show efficacy we are treating someone and then waiting to find out if our treatment even works,” explains Andrew Coop, PhD, professor in the Department of Pharmaceutical Sciences and associate dean for academic affairs. “Is that the way we should be practicing medicine?” Coop is part of research underway at the School of Pharmacy that hopes to develop a new antidepressant without the latency period. The NIMH-funded project is a collaboration among the School, Harvard University, University of Texas Health Sciences San Antonio, and the University of Michigan. Coop explains that there is significant evidence that scopolamine, a drug used to treat motion sickness, can treat depression without the lag time. However, it causes cognitive deficits such as reduced attention and concentration. “Our research collaborative wants to see if we can develop a similar muscarinic antagonist to scopolamine that retains the antidepressant action without the associated cognitive deficits,” he says. The work is in the preclinical stage now with a lead compound, CJ2100, a muscarinic antagonist that has proven effective at treating depression in animal models without the long latency period or negative cognitive side effects. A second compound is in development to enable the research to move to clinical trials. Coop hopes one day CJ2100 will be the foundation of a medication that can replace SSRIs and bring immediate relief to those with depression. “Depression is such a debilitating disease,” he says. “We need to reduce the latency period to alleviate the suffering of patients.” b
12
c a p su l e
www.pharmacy.umaryland.edu
of substance use disorder, which often occurs with mental health issues. Most recently, she completed a project funded by the Maryland Department of Health, which educated staff in community pharmacies on opioid use disorder, the overdose medication naloxone, medications available to treat opioid use disorder, and harm reduction strategies. The program reached 136 pharmacies. Understanding that substance abuse is both a public health issue in the United States as well as a health challenge for individual patients, DiPaula says the School has always been proactive about including substance abuse and mental health in its curriculum. “From a teaching perspective, even if you don’t think you will be specializing in psychiatry or substance use disorder, you will see patients in primary care or elsewhere who Bethany DiPaula will have psychiatric illness and/or substance use disorders,” she notes. “It is important to understand that if you’re going to manage the overall health of the patient.”
Mental Health in the Curriculum
Given the breadth of mental health issues and their prevalence, it is no surprise that it is a topic covered in various places throughout the School’s Doctor of Pharmacy (PharmD) curriculum. According to Andrew Coop, PhD, professor in the Department of Pharmaceutical Sciences (PSC) and associate dean for academic affairs, it is embedded in the curriculum like any other disease state. “Mental health education is as important, if not more important, than any other aspect of health,” he says. “It affects so many people that we have always covered mental health in the curriculum.” First-year students start with a fundamental understanding of the drugs that treat mental health in their Medicinal Chemistry course. In the Applied Sciences and Therapeutics series of courses, an entire module is dedicated to mental health. The topic is revisited again in the final years of the curriculum as part of Pharmacotherapy I and II. While all students are exposed to education in mental health, the elective Perspectives in Mental Health is available for those interested in specializing in the area. Through that course, students gain an understanding of the history of the mental health system, tools and techniques used in the assessment of psychiatric diseases, and current guidelines for psychiatric hospitalization, including civil and criminal commitment. Additionally, the course touches on contemporary issues such as the media’s perception of mental illness and mental health controversies a practicing pharmacist is likely to face.
Andrew Coop
Because mental health is so often intertwined with other health issues, it is embedded in coursework throughout the curriculum. “If we consider an area such as drug abuse, it is so connected to mental health that when we talk about drug abuse or when we talk about many of the conditions within the curriculum, mental health is always there and is always highlighted as an important component,” explains Coop.
A Healthy Student Experience
Students enjoy learning about mental health and are very engaged in it as part of the curriculum. Yet there can still be stigma associated with mental health challenges within the students’ own lives. “The academic experience is so different now and the environment is different than in years past,” says Layson-Wolf. “We realize a student’s well-being is strongly tied to their experience at the School.” Through dialogue with student leaders and in class meetings, students are encouraged to reach out when they are experiencing challenges related to anything, but particularly around matters of mental health. The School’s message is consistent — if someone is struggling or sees a colleague who might be struggling, they are to refer that student to Layson-Wolf or Coop. “The thing that makes me feel the best about how our students view the concept of mental health isn’t when a student self-identifies that he or she needs help. It’s when a student comes to me and says, ‘My friends told me to come see you,’” says Layson-Wolf. “That shows that friends recognized a change and encouraged that student to reach out.” In addition to fostering a safe environment where students can ask for help or refer a friend or colleague about whom they might be concerned, the School participates in formal programs to increase awareness of mental health issues and to destigmatize these disorders. In October, the Student Government Association, in partnership with the National Alliance of Mental Illness (NAMI) and the School’s student chapter of APhA, conducted a week of activities focused on dialogue about mental health. Events were hosted at the University’s SMC Campus Center to reach not only the School’s students but also colleagues in the other professional schools on campus. Branded with the hashtag #IWillListen, the week included many events like a “Day without Headphones,” to encourage students
to unplug and listen to each other, and a “Healthy Selfie” event to increase the dialogue about constructive ways to use social media. Students also were encouraged to sign a pledge underscoring why it is important to be compassionate listeners. All the events were intended to encourage open discussion so students understand it is OK to ask for assistance when it is needed. In the past, the School’s chapter of the College of Psychiatric and Neurologic Pharmacists has hosted panels where students volunteered to share their mental health history. “They talked to their colleagues about what that experience was like for them,” says Layson-Wolf. “I was really impressed with the students’ willingness to share because I think that colleague-tocolleague messaging is more meaningful. You see someone who is in the same place in life as you are and what they are going through.” Layson-Wolf says students are becoming more comfortable having these conversations, reaching out for help, and connecting with resources, like the University’s 24/7 hotline and Counseling Center, where the School has a designated point of contact — Marquette Turner, PhD. “Dr. Turner engages with me on a regular basis to talk about any patterns or issues he sees, while protecting student confidentiality,” Layson-Wolf explains. “It gives us a good connection with the Counseling Center because we have people who are very in tune to our community and the environment at the School of Pharmacy.” School faculty and staff recently underwent training to learn how to evaluate if a student is in crisis. Called Red Folder training, it was led by the Counseling Center in person at the School during the summer and via webinar in the autumn, with the resources available online for students. The training focuses on an actual Red Folder given to faculty and staff that contains a quick reference guide as well as information on how to recognize symptoms that a student is in distress, appropriate responses based on that assessment, and contact information for therapy or other immediate help. “As hard as I try, I can’t be everywhere and you never know when a situation may come up. It’s important that faculty and staff not try to navigate this on their own,” explains Layson-Wolf. “The nice thing about the training is it has all the important phone numbers in one place that a faculty or staff member could need to assist a student in crisis. It provides a lifeline for us to make sure we are providing the most appropriate help we possibly can.” Understanding and contributing to improved mental health, whether that means researching better medications for mental health disorders, working with state agencies to care for vulnerable populations, or providing safe spaces for students to discuss their challenges, will remain an essential part of the School’s mission. “We pride ourselves on being pre-eminent in our education related to mental health at the School,” says Eddington. “Our mandate moving forward will be to ensure that the School remains a leader in programming and best practices regarding mental health.” b sp ring 2 0 2 0
13
SPOTLIGHT ON RESEARCH Understanding Medication Use in Youth
Susan dosReis, PhD '99, a professor in the Department of Pharmaceutical Health Services Research, has studied pharmacoepidemiology (the utilization and impacts of drugs in population groups) for nearly two decades. Her expertise is in children and adolescents, particularly those served in the public sector by programs like Medicaid. Her current research focus includes using stated preference methods to investigate the benefit-risk tradeoffs that caregivers make when deciding to use a psychotropic medication for their child. She also uses integrated databases to examine the influence of community factors, like crime, poverty, and education, on the safe and effective use of psychotropic medications among children. dosReis’ research has evolved in tandem with advances in the treatment of mental health disorders in youth. She began her career when stimulant prescribing for young people with ADHD was on the rise. Today, there are not only stimulants approved for use in children but a host of psychotropics and other medications are available. But within that complex landscape, there are disparities. For example, youth in foster care served by Medicaid have a higher use of these medications. While there has been a national emphasis on decreasing prescriptions, dosReis notes that it’s important for policy to be informed by data. “The emphasis is on reducing unnecessary use of medications while
14
c a p su l e
www.pharmacy.umaryland.edu
ensuring that people have access to what they need to manage their condition,” she says. dosReis also studies the social determinants of health. “The impact I’ve seen from this work is the receptivity in state agencies to use data to inform how well their programs or policies intended to improve mental health outcomes are working and where there are unmet needs,” she states. “I’m excited that these agencies are onboard with incorporating [data] so they can identify children falling through the cracks.” Researching the rise of stimulant medications being prescribed to young people with ADHD early in her career opened the door to looking at caregiver perceptions of treatment and how that influenced their decision to initiate medication for their child (or to continue it if they did initiate it). At that time, dosReis created a caregiver perception survey called ASK-ME to ascertain caregiver preferences. She has since devised more sophisticated questionnaires that delve deeper into the benefit-torisk threshold for caregivers who must weigh the risk of side effects with the beneficial outcomes for their child that are most important to them. For example, dosReis just completed a survey of the benefitrisk tradeoffs of antipsychotic use in children and is looking forward to the results, which she anticipates will show not only how caregivers feel about the medication, but what
Susan dosReis side effects the caregiver is willing to tolerate if the tradeoff is that the child can function in school or stay home rather than go to an institution. “That gives us a lot more information about how individuals differ in their preferences, so we understand not just the [caregiver] attitude but what are the attributes of treatment that affect their decisionmaking,” dosReis says. She adds that the methodology is now expanding to look at how these preferences impact decision-making when evaluating whether treatment is cost effective or not, and which attributes of treatment are most influential in decisionmaking. This research would not be possible without engaged patients and caregivers. An aspect of dosReis' research is funded by the Patient Centered Outcomes Research Institute. It provides the “lived experience” that informs the research’s studies and surveys. “Through that patient-centered work, we’ve created an engaged patient community that feels part of a research team.” b
FACULTY PROFILE
Rave Reviews BY LOU CORTINA
How do you know you’ve made an impact as a teacher? When students flip the script and take time out of their busy lives to write recommendation letters for you. This is the case Francis Palumbo with Francis B. Palumbo, PhD, JD, MS, professor in the Department of Pharmaceutical Health Services Research (PHSR) at the School of Pharmacy (SOP). Palumbo was named the University of Maryland, Baltimore’s (UMB) Founders Week 2019 Educator of the Year, with his nomination bolstered by five letters from former students. And those raves are just the tip of the iceberg for Palumbo, a licensed pharmacist with a PhD in health care administration and a law degree, whose influence on students is expanded by his role as an adjunct professor at UMB’s Francis King Carey School of Law. “If I reached out today to 20 former students — many working for prestigious law firms and at the highest level at the Food and Drug Administration — and asked them to write a testimonial about Dr. Palumbo, they would jump at the chance,” says Virginia Rowthorn, JD, LLM, executive director of UMB’s Center for Global Education Initiatives and a former colleague of Palumbo’s at Carey Law. “He is incredibly warm, welcoming, and delightful.” Palumbo has been a member of SOP’s faculty since 1974, teaching pharmacy management, medical care organization, health economics, and pharmacy law. In the 1980s, he cofounded the School’s graduate program in pharmaceutical health services research as well as its Center on Drugs and Public Policy, of which he is executive director. He has mentored many master’s and PhD students. “I am extremely humbled to win the Educator of the Year Award since there are so many extremely talented faculty at
UMB,” Palumbo says. “I have been involved in many aspects of higher education, but my impact on the lives of my students gives me the greatest satisfaction.” One such former student is Noel E. Wilkin, PhD, provost at the University of Mississippi, who studied under Palumbo at SOP and worked with him while pursuing his PhD in PHSR. “Dr. Palumbo had a memorable influence on my commitment to the pharmacy profession,” Wilkin says. “He combines his legal knowledge and ability as a scholar to make significant contributions in one of the world’s most regulated professions.” Alan Lyles, ScD, MPH, the Henry A. Rosenberg Professor of Public, Private and Nonprofit Partnerships at the University of Baltimore, is another former student who sees Palumbo as a role model. “He was an approachable professor and generous with his time,” Lyles says. “Until I took Dr. Palumbo’s courses, I was thoroughly committed to pharmaceutical chemistry. After his courses, I was aware of larger possibilities. I have sought Dr. Palumbo’s counsel throughout graduate school, my years as a medical school administrator, and subsequently in academia. He has set a standard for teaching, learning, and mentorship that I strive to emulate.” Palumbo has produced countless journal articles, held leadership roles in national organizations, and chaired the Food and Drug Law Journal’s editorial advisory board. Students at SOP and Carey Law appreciate his deep knowledge of the subject matter, his thoughtful feedback on their papers, and his willingness to go the extra mile to help them with their research. The deans appreciate him, too. “Dr. Palumbo has applied his pharmaceutical and research training and practice to his academic career and made a great impact on our School and our students,” says Natalie D. Eddington, PhD '89, FAAPS, FCP, dean of SOP. Adds Carey Law Dean Donald B. Tobin, JD, “On our class evaluations, students have praised his mastery of the subject matter, his passion for the material, and his approachability. One student perhaps best captured his persona, describing him as ‘friendly, humble, and smart.’ ” b
sp ring 2 0 2 0
15
STAFF PROFILE
A Steady Source of Support BY ELIZABETH HEUBECK
Ask anyone who works at a university what they find most rewarding about their job, and the response is likely to center on students: their recruitment, their studies, their post-college landing. JuliAna Brammer JuliAna Brammer, MBA, considers herself fortunate. As director of admissions, records, and registration for the Doctor of Pharmacy (PharmD) program in the Office of Student Affairs at the School of Pharmacy, she connects with students during each stage of their academic journey. “It’s always changing. I get to do different things,” Brammer says. Her main priority stays the same, however. “I want students to know that our office supports them,” she says. According to her supervisor, Brammer also excels at supporting her colleagues. “I rarely hear her say no or see her blink an eye. She is a really valuable member of the team,” says Cherokee Layson-Wolf, PharmD ’00, BCACP, FAPhA, associate dean of student affairs, who lauds Brammer’s “get-it-done” attitude. Student recruitment for the PharmD program is an integral part of Brammer’s multifaceted job. She and a team of staff and student ambassadors travel to undergraduate institutions from California to Puerto Rico to introduce the School of Pharmacy to prospective students. Savvy marketing in a fluctuating environment is essential, too. “I need to make sure we’re implementing best practices as quickly as the landscape changes,” Brammer says. While she can’t control factors like changes in demand for pharmacists or the growing number of pharmacy schools nationwide, she can employ multiple recruiting tools to promote the School. These include outreach activities like attending high school and undergraduate career fairs as well as online and on-campus open houses; creating and disseminating marketing materials; and ensuring that the admissions office is accessible. Not all of Brammer’s potential recruits are ready to embark on graduate-level coursework. Some aren’t even in high school 16
c a p su l e
www.pharmacy.umaryland.edu
yet. But it’s never too early to learn about a given profession, and Brammer relishes being the one to inform youngsters about pharmacy. “I worked at a nonprofit where I helped young clients with career development and skills training. I really enjoy that piece of what I do,” she says. Brammer uses creative strategies to introduce local students, mainly those in middle school and high school, to the School. Referred primarily through the University of Maryland, Baltimore's Office of Community Engagement, the young students come to campus and engage in hands-on activities like making lip balm, a fun introduction to the science of compounding pharmacy. They end with a School tour and a visit to the School’s museum, where they peer at pharmacy relics dating back to the 18th century — objects like packaging from diabetic ice cream and cigarettes for asthmatics that make young people appreciate how far the profession has come. As supervisor of the Office of Student Affairs, where she oversees three staff members and five student employees, Brammer is often the first person to respond to students in need. “If somebody is emotionally in crisis, it takes active listening skills and knowing what resources exist to help them,” Brammer says. Support goes both ways, she explains. Current PharmD students play an integral role in Student Affairs functions by volunteering at events such as admissions interviews, orientation, and the White Coat Ceremony. “I appreciate their contribution toward our efforts at making incoming students feel welcome,” Brammer says. Perhaps the most rewarding aspect of her job, reflects Brammer, is witnessing students graduate — a capstone event overseen by Student Affairs. “That’s a really special time, when you see them onstage and you see their families,” Brammer says. “It’s a privilege to be one of the first to welcome students into the School, to support them during their education, then to see them graduate and go on to careers or residencies they have worked so hard to attain.” When she’s not supporting students, Brammer spends time with her husband, 3-year-old son, and 10-year-old daughter. In her spare time, the die-hard Ravens fan also enjoys yoga, outdoor activities, and traveling. b
STUDENT NEWS
Healthy (and Happy) Halloween Several Student Government Association organizations partnered to host the School’s annual Healthy Halloween for students participating in the University of Maryland, Baltimore’s CURE Scholars Program. b
Members of the Students Promoting Awareness organization, from left: Carla Quinones and Laurie Fontan Cepeda of the Class of 2023; Katherine Owens and Sapna Basappa, Class of 2022; and Alexandra Morris, Class of 2023.
Members of the College of Psychiatric and Neurologic Pharmacists promoted de-stressing with stress balls. From left: A CURE scholar, Zachary Leppert, Anna Rubino, and Rita Chen, all of the Class of 2021.
American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP) members educated CURE students on healthy lifestyle choices and provided healthy snacks for the children. From left: Michelle Nguyen, Class of 2021; Pearl Li and Cradesha Perry, Class of 2023; and Allison Dunn, Emily Mcdougall, and Amy Bao, all of the Class of 2021.
The Pediatric Pharmacy Advocacy Group and APhA-ASP Operation Immunization teamed up to discuss the importance of hand hygiene and hand washing. From left: Brian Sistani and Eun Bi Kim, Class of 2022; Jemini Patel, Class of 2021; Adam Bennett, Class of 2023; and Daniel Trisno, Class of 2022.
sp ring 2 0 2 0
17
STUDENT NEWS
U.S. Public Health Service Information Session
Kappa Psi Steps Out
In September, the School hosted a career information session with representatives from the U.S. Public Health Service (USPHS), where they discussed the Indian Health Service, the USPHS JRCOSTEP/SRCOSTEP Internship program, and student shadowing opportunities at the Centers for Medicare and Medicaid. b
Kappa Psi Sigma chapter members from the Class of 2022 Kristi Adachi, Esther Kim, Minh Ta, Daniel Trisno, and Zaid Rahman volunteered at the Step Out Diabetes Walk in October at the Canton Waterfront Park in Baltimore. Students at the information session pose with USPHS officers from the U.S. Food and Drug Administration.
APhA-ASP Has a Busy Fall The School’s chapter of the American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP), the largest student government organization at the School, hosted and participated in several events during the fall semester. b
In October, APhA-ASP’s Operation Immunization partnered with Walgreens and the University of Maryland, Baltimore’s (UMB) Health Sciences and Human Services Library to host two flu shot clinics for faculty, staff, and students. During the two-day event, students administered 265 vaccines. Back row, left to right: Xin Gao, Class of 2020; a Notre Dame of Maryland University School of Pharmacy student; Tony Kearney, RPh, of Walgreens; Alexandra Clyde, Class of 2021; Olivia Thomas, Class of 2022; and Griffin Guardala, Class of 2021. Front row, left to right: Katherine Tieu, Class of 2023; Stella Kim, Class of 2022; and Sachi Patel, Class of 2021.
APhA-ASP members and students from UMB's School of Dentistry and the School of Medicine’s physical therapy program volunteered at the Hollins Health Fair in October to provide free health education to Baltimore residents. Components included a fall risk prevention workshop, flu shot administration, and diabetic foot and blood pressure screenings. 18
c a p su l e
www.pharmacy.umaryland.edu
IPhO Takes a Field Trip Members of the Industry Pharmacists Organization (IPhO) visited AstraZeneca in Gaithersburg, Md., in November. b
Standing from left: Paulina Kepczynska, Adaeze Amaefule, Meghna Bhatt, and Amanda Dinh, all of the Class of 2022. Kneeling and sitting from left: Pavan Patel, Class of 2022; Alexandra Wilson, Class of 2023; Anna Dizik, Class of 2021; Simone Nasroodin, Class of 2023; Yang Lu, and Abel Kwong, Class of 2023.
ASHP on the Road Members of the Student Society of Health-System Pharmacists visited the headquarters of the American Society of Health-System Pharmacists (ASHP) in Bethesda, Md., in October. b
From left: Sean Kim, Class of 2023; Biva Kamal, Class of 2022; Lucia Hwang, Class of 2023; Minlang “Claire” Lin and Drashti Vasaiwala, Class of 2022; and Trexy Palen, Delaney McGuirt, and Jason Van, all of the Class of 2023.
AMCP Hosts Mid-Atlantic Regional Conference The School’s student chapter of the Academy of Managed Care Pharmacy (AMCP) hosted the first Mid-Atlantic Regional Conference in Pharmacy Hall in September. This two-day student-organized conference brought together a large group of aspiring pharmacists from the country’s top PharmD programs to learn from prominent managed care and pharmaceutical industry leaders. b
Conference coordinators from UMSOP, the University of North Carolina, and Rutgers University with Susan Cantrell, RPh, CAE, chief executive officer of AMCP and the conference’s keynote speaker (center in striped sweater).
sp ring 2 0 2 0
19
STUDENT NEWS
White Coat Ceremony Family and friends joined faculty, staff, and alumni of the School of Pharmacy in September to watch as more than 120 student members of the PharmD Class of 2023 donned a pharmacist’s white coat for the first time during the School’s annual White Coat Ceremony for incoming student pharmacists. A tradition in which schools of pharmacy across the country participate each year, the White Coat Ceremony celebrates the start of the class journey as student pharmacists. b
Tecoya Farrakhan, PharmD ’02, MBA, CHC, dispensary manager and clinical director for Curio Wellness, served as guest speaker for the event. Building on the theme of professionalism, Farrakhan shared important lessons learned from her own career with students, underscoring the need for future pharmacists to be able to balance skills with personality, communicate well with others, network at every opportunity, and be open to change.
Students recite the School’s Pledge of Professionalism.
The Class of 2023 20
c a psu l e
www.pharmacy.umaryland.edu
Yijie Cheng receives her white coat from Chanel Whittaker, PharmD, associate professor in the Department of Pharmacy Practice and Science.
Alex Livingston shakes hands with Dean Natalie D. Eddington, PhD ’89, FAAPS, FCP, after receiving his coat.
Strength in Numbers Members of the School’s chapter of the American Society of Consultant Pharmacists (ASCP) attended the organization’s Mid-Atlantic Meeting in Gettysburg, Pa., in August, where students and preceptors from East Coast schools of pharmacy came together for professional development. b
ASCP student members and UMSOP faculty and staff with colleagues from Howard University, Notre Dame of Maryland University, and the University of Maryland, Eastern Shore.
Phi Delta Chi Gives Back
Standing from left: Pinky Shah, Emily Mcdougall, and Michelle Nguyen, Class of 2021; Ryan Mihaly, Stephen Fendt, and Brian Sistani, Class of 2022; Bernard Cabatit, Class of 2020; Maryann Agnello, Andrew Sybing, Eldin Burek, Brady Wilburn, and Nehal Ahmed, all of the Class of 2022; James Mease, Class of 2021; and Jeffrey Banaszak, Garrett Crawford, and Sapna Basappa of the Class of 2022. Kneeling from left: Lauren Proctor and Hanna Lefebo of the Class of 2022.
Phi Delta Chi (PDC) prides itself on collaboration with local organizations such as the Ronald McDonald House, Hope Lodge, and Paul’s Place. PDC brothers of the School’s Iota chapter spend a large amount of time volunteering. They also contribute to the national Phi Delta Chi Philanthropy that raises money for national pediatric cancer research. A sizable portion of their fundraising profits nationwide are donated to St. Jude Children’s Research Hospital. The Iota chapter’s annual Penny Wars competition took place in November, at which $400 was raised. b
Laurels The School of Pharmacy’s student chapter of the American Association of Pharmaceutical Scientists has been named the association’s 2019 Student Chapter of the Year. Husam Albarmawi, MS, BPharm, a PhD student in the Department of Pharmaceutical Health Services Research (PHSR), received the department’s Dr. Arthur Schwartz Memorial Scholarship Award. Meron Assefa, a fourth-year student pharmacist, was a member of the University of Maryland, Baltimore’s (UMB) first place-winning team in the National Academy of Medicine’s Public Health Challenge.
Sharmila Das, a PhD student in the Department of Pharmaceutical Sciences (PSC), received the 2019 Graduate Student Award from the American Association of Indian Pharmaceutical Sciences. Amy Defnet, a PhD student in PSC, received a Best Poster Award at the International Union of Biochemistry and Molecular Biology meeting in September in Warsaw, Poland. Bansri Desai, PharmD, a PhD student in PHSR, received the department’s Harris Zuckerman Scholarship. Third-year student pharmacist Anna Dizik, second-year student pharmacist Andrew Sybing, and first-year student pharmacists
Delaney McGuirt and Alexandra Wilson won the local Pharmacy & Therapeutics Competition of the Academy of Managed Care Pharmacy Foundation. Arissa Falat, a secondyear student pharmacist, received the Tylenol Future Care Scholarship. Aakash Gandhi, BPharm, a PhD student in PHSR, received the department’s Student Travel Scholarship. He also won the Best Student Poster Award at the International Society for Pharmacoeconomics and Outcomes Research Europe Meeting in Copenhagen, Denmark, in November. Rosie Love, MPH, a PhD student in PHSR, received the
department’s Donald O. Fedder Memorial Fellowship. Jennifer Miller, a fourth-year student pharmacist, received the Phi Lambda Sigma Book Award. Sharonne Temple, a first-year student pharmacist, received a UMB Center for Global Engagement grant for her project “Examining Barriers to PrEP Use among Adolescent Girls and Young Women in Botswana.” Sherin Thomas and Dongyue Yu, both PhD students in PSC, received the department’s Dr. Gerald P. and Margaret M. Polli Graduate Student Travel Awards to present posters at the AAPS’ Annual Meeting in November in San Antonio. sp ring 2 0 2 0
21
PRECEPTOR PROFILE
Bursting the Bubble BY RANDOLPH FILLMORE
Julie Caler
Julie Caler, PharmD ’06, BCGP, BCPS, CPSO, a clinical pharmacist at the Western Maryland Regional Medical Center (WMRMC) in Cumberland, Md., has a philosophy on precepting fourth-year pharmacy students. “I love teaching and giving students the chance to get out of the ‘academic bubble,’” says Caler, who has been at WMRMC since 2007. “I like to be brutally honest, providing them with real-world experience by showing them the realities of clinical pharmacy and helping them find out if clinical pharmacy is a good fit for them.” Alex Le, a fourth-year student completing the clinical track at WMRMC, agrees that being face-to-face with patients is quite different from his classroom and textbook work. “This is a unique and challenging experience,” says Le. “Dr. Caler integrates me into her workflow and challenges me to find my own answers to patient problems. She takes time to discuss each patient, and we figure out how we might modify their medications. She treats me like a colleague.” As a clinical pharmacist, Caler works closely with patients, many of whom are elderly and rehabbing after fractures or strokes. Medication reconciliation is a priority to ensure medication safety and efficacy as patients transition on and off the unit, she says. Caler also is an instructor for diabetes selfmanagement and assists with antibiotic stewardship. In her youth, Caler spent a lot of time volunteering in nursing homes in her native Pennsylvania. Eventually, her family relocated to Towson, Md. After several years, Caler returned to Pennsylvania to attend Lehigh University in Bethlehem, where she was a biology major. She entered the University of Maryland School of Pharmacy in 2002 and
22
c a psu l e
www.pharmacy.umaryland.edu
received her PharmD in 2006. Who were her important mentors at the School? Nicole Brandt, PharmD '97, MBA, BCPP, CGP, FASCP, professor in the Department of Pharmacy Practice and Science (PPS) and executive director of the Peter Lamy Center on Drug Therapy and Aging, was a key mentor during her training as a student and resident, explains Caler. She also gained critical skills both from the late Fred Abramson, BSP ’56, an assistant professor in PPS who oversaw the pharmacy practice lab, and the late Robert Michocki, PharmD ’75, BCPS, a professor emeritus in PPS. According to Agnes Ann Feemster, PharmD, the School’s assistant dean of experiential learning and an associate professor in PPS, Caler and Western Maryland offer a very different learning environment than urban hospitals in Baltimore, exposing students to pharmacy practice in a rural setting and the unique challenges of the patients who live there. “As one of the School’s Preceptors of the Year in 2017, Dr. Caler demonstrates a passion for teaching and is vested in developing our students into being independent practitioners,” Feemster says. “Because of her varied practice background, she precepts students for a variety of patient care and non-patient care elective rotations, and many of our required rotation experiences. She invests in each student, tailors each rotation to the needs of the student, and maximizes every learning opportunity.” When Caler is not working, she enjoys supporting local rescue efforts for animals in the community, through advocacy, fostering, and transporting. b
ALUMNI NEWS
A Message from Alumni Affairs I’m often asked what makes a successful alumni relations program. The question isn’t necessarily what, but who makes an alumni relations program successful. The answer is simple: people. Establishing and maintaining meaningful relationships with our alumni is a key measure of success. As the pages in this magazine show, we have hosted numerous alumni gatherings and student-led community events in recent months. It has been wonderful to see so many alumni participate in activities both at the School and at other venues, and especially nice to see many alumni connect back to the School and Greer Griffith with each other for the first time since graduation. Our continued success and growth is dependent upon our alumni’s willingness to give their time, energy, expertise, and resources. It’s important also to recognize the crucial role that donations play in the School’s drive to maintain excellence. Alumni contributions support faculty research, attract top students, establish scholarships and fellowships, impact national rankings, and build educational programs, such as our new MS in Medical Cannabis Science and Therapeutics. Without these gifts, it would be difficult for the School to maintain the exceptional education, practice, research, and community programs for which we are known. Gifts come in many forms, but a successful alumni relations program relies on one very important gift: the gift of time. Alumni relations programs strive to build, strengthen, and sustain relationships with the alumni community. Success in building that community is dependent on your participation. The more alumni who become involved, the more robust and valuable our alumni network becomes. Alumni who volunteer their time to speak to our students, attend events, recruit future students, participate on alumni boards, or volunteer for School of Pharmacy initiatives contribute immeasurably to our success. Alumni are our greatest voice, and we rely on you to serve as advocates for the School. Thank you to all our alumni for your continued support, engagement, and advocacy.
Gratefully, Greer Griffith, MS Director of Alumni Relations and Annual Giving Office of Development and Alumni Affairs P.S. Please feel free to reach out if you are interested in becoming more involved with the School. You can contact me at ggriffith@rx.umaryland.edu.
Alumni Association Executive Committee 2019-2020 Kelcymarie Bye, PharmD ’16 President
Geoffrey Heinzl, PhD ’16 Secretary
Michael Beatrice, PhD ’01
Kristine Parbuoni, PharmD ’05 President-elect
David Ngo, PharmD ’13 Treasurer
Denise Fu, PharmD ’10
Robyn Firmin, PharmD ’17 Past president
Capt. James Bresette, PharmD ’97 C. Lawrence Hogue, BSP ’69 Aicha Moutanni, MS ’17 Magaly Rodriguez de Bittner, PharmD ’83 Marci Straus, PharmD ’12
sp ring 2 0 2 0
23
ALUMNI NEWS
Class Notes 1953
1997
2013
Philip Karn, BSP, has been living at Roland Park Place senior living community in Baltimore for more than four years. He would like to chat with any member of the Class of 1953. Please contact the Office of Development and Alumni Affairs at alumni@rx.umaryland. edu for his phone number and email address.
Tony Guerra, PharmD, received the Phi Delta Chi 2019 Selfless Servant Award, which recognizes alumni who have gone above and beyond to give back and serve the fraternity.
Kashelle Lockman, PharmD, was recognized by the University of Iowa College of Pharmacy’s Class of 2021 as its Teacher of the Year. She also received the American College of Clinical Pharmacy’s 2019 New Educator Award.
1968 Arnold Honkofsky, BSP, was featured in The Baltimore Sun in September 2019 for his volunteer work with Greater Baltimore Medical Center’s (GBMC) signature event, the Legacy Chase at Shawan Downs. The event, which includes steeplechase horse races and food trucks, benefits oncology services and patient support programs at GBMC. The article also highlighted Honkofsky’s support for Death With Dignity legislation.
1984 Matthew Shimoda, PharmD, recently joined the Notre Dame of Maryland University School of Pharmacy as its assistant dean of student affairs.
1989 Kim D. Tanzer, BSP, was appointed president of the Massachusetts Board of Registration in Pharmacy.
1998 Kimberly Couch, PharmD, and her husband, Paul, are the proud parents of son Gregory, age 14, who is celebrating three years as a founding member of the Maryland MidShore Chapter of Project Linus, a national nonprofit organization that provides new, handmade blankets for children in need. Gregory and Kimberly have donated 750 quilts, afghans, and fleece blankets to children in need in the MidShore area.
2006 Joseph LaRochelle, PharmD, received the Phi Delta Chi 2019 Selfless Servant Award, which recognizes alumni who have gone above and beyond to give back and serve the fraternity.
We want to know what’s happening with you! Please send us updates on your personal and professional life. Have you changed jobs, had a recent promotion, received an honor or appointment? Did you recently get married or celebrate the birth of a child or a grandchild? Do you have an interesting hobby or participate in community service projects? Please let us know by completing the School of Pharmacy’s online Class Notes form at www.pharmacy.umaryland.edu/ alumni/resources/class-notes/.
2008 Jamie Wilkins, PharmD, and Laura Zendel, PharmD, received the U.S. Food and Drug Administration’s Frances O. Kelsey Drug Safety Award for their development and review of the Palynziq REMS.
In Memoriam The University of Maryland School of Pharmacy honors the lives and memories of the following alumni who passed away between Jan. 1, 2019, and July 1, 2019. We are grateful to each of these alumni for the lasting impact that they made on the School community and the advances they achieved in pharmacy education, research, or practice. Alfred Abramson, BSP ’56 Kenneth S. Bauer Jr., BSP ’89 Richard J. Brodeur, MS ’65 David C. Clarke, BSP ’52 Betty W. Cohen, BSP ’49 Barry A. Edelman, BSP ’69
Richard M. Goodman, BSP ’67 Marvin B. Jaslow, BSP ’58 Beryl Lerner, BSP ’61 Howard E. Mandel, BSP ’50 Annette Padussis, BSP ’82 Irving J. Raksin, BSP ’60
Stanley Scherr, BSP ’54 James B. Walter Jr., BSP ’51 Milton M. Waxman, BSP ’38 Morton H. Weiner, BSP ’50
If you would like to make a memorial gift, please use the enclosed giving envelope or call 410-706-5893. 24
c a psu l e
www.pharmacy.umaryland.edu
PSC Grad Gathering The Department of Pharmaceutical Sciences (PSC) hosted its third biennial PSC and Regulatory Science Grad Gathering at the School of Pharmacy in September. Organized by the PhD in PSC, the MS in PSC, and the MS in Regulatory Science programs, the daylong event featured a wide range of activities designed to foster networking and professional development among attendees. b
From left: PSC graduate students Alecia Dent and Ramon Martinez; Paul Shapiro, PhD, professor and chair of PSC; and Katherine Joyner, PhD ’13.
From left: Balvinder Vig, PhD '01; Aaron Smith, PhD ’15; Angela Wilks, PhD, the Isaac E. Emerson Chair of Pharmaceutical Sciences; and Steven Fletcher, PhD, associate professor in PSC.
Angela Wilks moderates a panel with alumni, from left, Pallavi Nithyanandan, PhD ’05; Heather Boyce, PhD ’17; Brittany Avaritt, PhD ’14; Maura O’Neill, PhD ’13, and Daniel DeCiero, MS ’18.
Attendees enjoyed a happy hour at the Union Wharf Clubroom at the end of the day.
Ritu Lal, PhD ’96, MS, chief executive officer and co-founder of GEn1E Lifesciences, delivered the keynote address.
ASHP Mid-Year Alumni and Friends Reception More than 200 alumni, faculty, staff, residents, and students attended the School’s reception at the American Society of Health-System Pharmacists (ASHP) Mid-Year Meeting in Las Vegas in early December at the Mandalay From left: Lynette Bradley-Baker, BSP ’92, PhD ’99; Anthony Guerra, PharmD ’97; Bay Resort and Casino. b
Soumi Saha, PharmD ’07; Michelle Rager, PharmD ’07; Steven Allison, PharmD ’06; Kristine Parbuoni, PharmD ’05, associate professor of pharmacy practice and science; and Karla Evans, BSP ’93.
sp ring 2 0 2 0
25
Q&A with Alumni Association Secretary Geoffrey Heinzl, PhD ’16
Geoffrey Heinzl
Where are you from? I am originally from Pittsburgh. I attended Allegheny College, where I double-majored in chemistry and French before moving to Baltimore for my graduate studies.
Why did you choose the University of Maryland School of Pharmacy? When searching for graduate programs, I wanted to find a school where the study of medicinal chemistry was more than applied organic chemistry. I searched for a collaborative, holistic view of drug discovery and was delighted to find it here in the Department of Pharmaceutical Sciences. The coordinated approach to research was immediately evident during my interview at the School, and I left hoping that I would get the opportunity to experience it firsthand.
Where do you work and what do you do there? I am a biomedical life scientist at Leidos, Inc., supporting the Congressionally Directed Medical Research Programs in the Department of Defense. I serve as the scientific manager for the Military Operational Medicine Research Program and the newly founded Chronic Pain Management Research Program. I coordinate and facilitate programmatic review meetings, in-progress review meetings, and other review meetings as needed for the execution of Congressional Special Interest programs and other military biomedical research programs.
What inspired you on this career path? Looking back at my time in graduate school, I realized that my favorite days were filled with activities that I performed as
26 26
c caapsu p sullee
www.pharmacy.umaryland.edu www.pharmacy.umaryland.edu
part of various student government organizations [including serving as president of the University of Maryland, Baltimore Student Government Association]. I felt like I was making an impact on the School and improving the student experience. I decided that I wanted a career that empowers scientists and researchers. To that end, I was excited to find an opportunity working in the research funding process, with the hope of eventually finding my way into the field of science policy. I want future researchers to feel supported and inspired, not fearful of dwindling funding and cumbersome administrative processes, so I’m dedicating myself to creating that future.
Why are you involved with the School’s Alumni Association? The Alumni Association offers a great resource for all of the School’s students and alumni, but accessibility can seem limited or the resources less applicable to students not pursuing a PharmD degree. I want to represent the School’s other students and alumni, including PhD and MS degreeseekers, and ensure that the Alumni Association makes its resources applicable and available to all of the School’s students and alumni.
What advice do you have for your fellow alumni regarding staying connected to the School? Staying connected to the School is as easy as staying connected with our fellow alumni. We’re our own best resources, and we can be found all over the state and beyond. Keep us in mind when opportunities become available, and we’ll do the same for you.
ALUMNI PROFILE
Making the Most Out of a Tight Schedule BY ELIZABETH HEUBECK
Mena Gaballah, PharmD ’18, JD ’18, knows a thing or two about time management. Gaballah, an intellectual property and health care associate at the law firm Crowell & Moring, LLP, graduated Mena Gaballah from the School of Pharmacy in 2018. That same year, he also earned a degree from the University of Maryland Francis King Carey School of Law. It’s hard to fathom the intense schedule required to obtain a law degree and a pharmacy degree simultaneously, let alone actually pursue it. But Gaballah seems to have taken it in stride. What’s more, he humbly credits faculty at both schools with making the intense schedule work. “While it was tough, it was manageable. People who were understanding made things a lot easier,” says Gaballah, who intentionally pursued the dual degree in order to be able to use a clinical and scientific background in the practice of law. He points to Cherokee Layson-Wolf, PharmD ’00, CGP, BCACP, FAPhA, the School of Pharmacy’s associate dean for student affairs, as a faculty member key to his success. According to Layson-Wolf, Gaballah’s somewhat rare academic circumstances coupled with his proactive nature turned out to be mutually beneficial. One of the first students she advised through the dual degree, Gaballah provided Layson-Wolf with an insider’s perspective of the challenges it presented. Together, they met regularly with Crystal Edwards, JD, MA, assistant dean for academic affairs at Maryland Carey Law. “These exchanges helped inform our interactions with other dual-degree students,” Layson-Wolf observes. While coordination of academic scheduling between the two schools helped Gaballah flourish in the classroom, he also made time as a dual-degree student to pursue several beneficial
extracurricular experiences. As a first-year pharmacy student, he competed in the National Community Pharmacist Business Plan Competition. Over several months, he and three other students developed an opioid and controlled substance insurance plan. Gaballah also co-authored an opinion piece in The Baltimore Sun calling for tighter regulation of improperly used over-thecounter substances. Co-authors included Neal Reynolds, MD, co-director of the Multi-Trauma Intensive Care Unit at the R Adams Cowley Shock Trauma Center, and Thomas Scalea, MD, FACS, FCCM, physician-in-chief at Shock Trauma. Authoring this timely essay alongside key members of Shock Trauma’s leadership team speaks to Gaballah’s maturity as a student. It also demonstrates the profound influence that his fourth-year critical care rotation at the R Adams Cowley Shock Trauma Center had on his overall experience as a pharmacy student. He points to attending pre-rounds, seeing very complicated multi-trauma patients, and collaborating with the medical team as some of the highlights of his academic career. But it wasn’t just the clinical rotation’s intense, adrenalineboosting nature that broadened Gaballah’s knowledge base — and prepared him for the future. After completing 10- to 12-hour days at Shock Trauma, Gaballah would head straight to the law school for classes. The demanding pace challenged his stamina. But a breakneck schedule seems to have become Gaballah’s norm. In his first postgraduate job as a lawyer providing fullservice intellectual counseling services to a range of clients — including pharmaceutical, chemistry, biotechnology, and materials science technologies — Gaballah has little downtime. “It can be fairly intense,” he says of working on several different projects simultaneously. But it’s a path he’s happy he chose. “My PharmD was integral to both landing and excelling at my job. Having a strong clinical and scientific background allows me to grasp concepts quickly and put to use what I learned in pharmacy school,” Gaballah says. b
sp ring 2 0 2 0
27
In Service to Others All of us are influenced by the events and experiences in our lives. When we received an email about an alumnus of ours, we decided to share his unique story, which captures this essence.
Herbert Friedman
Herbert Friedman, BSP ’50, was born in Vienna, Austria, in December 1924. In 1938, with the threat of war looming and being of Jewish heritage, he escaped from Vienna at the age of 14 onboard a children’s train bound for England. A year prior, Mr. Friedman and a friend were on their way home when they spotted a girl struggling to swim in the Danube River. They quickly jumped into the river and saved her life. Their actions earned them notoriety in the local newspaper and in turn helped Mr. Friedman escape from Austria and ultimately the Holocaust. After living in an orphanage in England, Mr. Friedman landed in Baltimore through the aid of a sponsor. He attended Forest Park High School before enrolling in the University of Maryland School of Pharmacy, where he was a member of the Rho Chi Honor Society. The spirit of helping others did not end with him saving the girl from the river in 1937. In fact, Mr. Friedman has spent the rest of his life helping others. Upon graduation, he began working at Read’s Drug Store on Gay Street. With a desire to serve his new country, he joined the
28
c a p su l e
www.pharmacy.umaryland.edu
Army, becoming a medic in the Pacific during World War II and overseeing the hospital pharmacy at Fort Lee, Va., during the Korean War. Following his military service, Mr. Friedman owned a pharmacy in Chesapeake, Va. He and his wife of more than 68 years, Joyce, owned and operated Portlock Pharmacy for more than 30 years. His three children worked at the pharmacy’s soda fountain and made deliveries to customers. The Portlock Pharmacy was a place to gather. A place to sit and talk. And, of course, a place to meet and be helped by “Doc” Friedman. Mr. Friedman was at his happiest while working at the pharmacy. Following his retirement, Mr. Friedman returned to work at the Naval Pharmacy in Norfolk, Va., before returning home to Baltimore where he has lived since, always feeling a great debt to the country that welcomed him, and to those who provided him an education and a means of making a living. Now 95, he has always loved pharmacy and the opportunity to serve. b
DONOR PROFILE
Loyal to Students Even in Retirement BY GWEN NEWMAN
Bob and Kathy Beardsley
For 42 years, Robert Beardsley, PhD, has played a pivotal role at the School of Pharmacy. A practicing pharmacist turned educator, mentor, and advocate for the profession, Beardsley has had quite a career. He is the recipient of more than a dozen prestigious awards, has developed that many courses in the School’s Doctor of Pharmacy (PharmD) program, and has helped create its dualdegree programs. He authored a textbook — Communication Skills in Pharmacy Practice — now in its seventh edition that sells about 4,000 copies each year worldwide, has advised and mentored hundreds of students, and was three times named Teacher of the Year by the School’s graduating PharmD class. It’s little surprise then that after a career of such distinction, Beardsley chooses to give in a way that greatly impacts students. He and his wife, Katherine Pedro Beardsley, PhD, former associate dean at the University of Maryland, College Park’s (UMCP) College of Behavioral and Social Sciences (BSOS), have endowed five annual scholarships — at the School of Pharmacy, UMCP, and Oregon State University (OSU), their shared alma mater. At the School of Pharmacy, the Beardsleys’ endowed scholarship helps students financially while preparing for their future careers. That was important to the couple. The Beardsleys met on the OSU campus in the late 1960s while in the marching band. They have marched in step ever since. Known for hosting departmental events at their home in Ellicott City, he invests time and energy into do-it-yourself home improvement projects. She continues to serve on the board of visitors for UMCP’s BSOS. They are parents to son Kyle, now a professor of political science at Duke University. Education is in the family blood, and Beardsley says the couple is now happy to help others. “Many individuals supported us as well as our son both financially and as mentors,” he said. “We felt it important to do the same.” The School is honored by their support and dedication. “I knew of Bob’s renown prior to joining the School of
Pharmacy five years ago and have been privileged to work with him,” says Ken Boyden, JD, EdD, associate dean of development and alumni affairs. “From day one, I’ve been extraordinarily impressed with his service to the School — updating the Strategic Plan, leading committees, how the needs of students always come first. He and Kathy have put that sentiment into action through their scholarship.” A 1972 graduate of OSU, Beardsley then earned a master’s and a PhD, both from the University of Minnesota. He spent several years working in a U.S. Public Health Service hospital in New Orleans, then shifted into the academic arena — a natural move given his love of teaching combined with research. Beardsley joined the School of Pharmacy in 1977, rising from assistant professor to associate dean for student affairs. He also served as vice chair for education and vice chair for administration in the Department of Pharmaceutical Health Services Research. His final title is professor emeritus, an honor bestowed upon select faculty as they retire, which Beardsley did in December 2019. Among the many awards and accolades he has received, Beardsley says he was most honored to receive the American Association of Colleges of Pharmacy’s (AACP) Distinguished Educator Award and the University of Maryland, Baltimore’s Diversity Recognition Award. He served two terms on the board of AACP and spent six years (two as president) on the board of the Accreditation Council for Pharmacy Education (ACPE). He facilitated the formation of the Maryland Pharmacy Coalition, helped found Hospice Services of Howard County, and is currently teaching within the American College of Clinical Pharmacy’s Leadership Academy. In retirement, he plans to continue his work in pharmacy education by working with ACPE’s international services program to assist other countries improve how they educate their pharmacists. b sp ring 2 0 2 0
29
RESIDENT PROFILE
A Change for Better BY LYDIA LEVIS BLOCH
Inspired by his pediatrician father, Sandeep Devabhakthuni, PharmD, BCCP, intended to become a physician. During his senior year of college, Sandeep Devabhakthuni though, he realized he no longer was passionate about medicine. Following an experience studying HIV medications, Devabhakthuni determined he wanted to help patients with their medication regimens. “I became a pharmacist to have an impact on medication use,” he says. After earning a Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy, Devabhakthuni undertook a life-altering pharmacy practice residency at the University of Maryland Medical Center (UMMC) in 2009. He then completed a second postgraduate residency back in Pittsburgh in cardiology and critical care. In 2011, he returned to Baltimore, this time as an assistant professor at the University of Maryland School of Pharmacy. “Why did I return?” Devabhakthuni asks. “I was really impressed by the University of Maryland when I did my first residency and appreciated the mentorship I received, in particular from Dr. Watson,” he says, referring to Kristin Watson, PharmD, BCCP, associate professor in the Department of Pharmacy Practice and Science (PPS) and the department’s vice chair for clinical services. “She is still my mentor today,” he adds. Now Devabhakthuni is an associate professor in PPS and is director of the School’s residency and fellowship program, the very program in which he participated as a resident in 2009. The program, a partnership between the School of Pharmacy and UMMC, accepts recent PharmD graduates from any school or college of pharmacy for a one- or two-year residency or
30
c a p su l e
www.pharmacy.umaryland.edu
fellowship position. Residents specialize in pharmacy practice areas such as toxicology, pediatrics, pharmacotherapy, critical care, and ambulatory care, receiving the additional training and education they need to practice more direct patient care. The program offers 14 specialties for residents and four for fellows. Nationwide, there are only a few schools of pharmacy offering as extensive a program as the one Devabhakthuni directs. Since 2016, a total of 44 residents and fellows have completed the program. Currently, 26 are enrolled. Upon completion, about two-thirds of the residents opt to work in a clinical setting, while one-third embark on careers in academia. Devabhakthuni estimates he has personally trained approximately 50 residents and fellows. “It’s fun to see the trainees’ faces light up when they grasp a concept, and it’s rewarding to know that I’m influencing a future generation of pharmacists who will make their patients’ lives better,” he says. Devabhakthuni’s enthusiasm for teaching and learning has not gone unrecognized. He has amassed awards such as the Class of 2018’s Faculty Member of the Year, 2016 University of Maryland Residency and Fellowship Preceptor of the Year, and Maryland Society of Health-System Pharmacy’s 2013 Pharmacist of the Year. In addition to his oversight of the residency and fellowship program, Devabhakthuni teaches in the School’s Doctor of Pharmacy program, serves as a preceptor for student pharmacists on rotations, and is a board-certified cardiology specialist practicing in the inpatient cardiology service and outpatient heart transplant clinic at UMMC. His research focuses on appropriate use of cardiovascular medications and sedation in mechanically ventilated patients. For relaxation, Devabhakthuni, who is from West Virginia, can be found outdoors hiking mountains or traveling. His most recent adventures took him to Costa Rica and India, but for him, Baltimore is home. b
2017-2018 ANNUAL REPORT
sp ring 2 0 2 0
31
LEADERSHIP
LEADERSHIP
Dean Natalie D. Eddington, PhD, FAAPS, FCP Senior Associate Dean for Administration and Finance William J. Cooper, MBA Associate Dean for Academic Affairs Andrew Coop, PhD Associate Dean for Clinical Services and Practice Transformation Magaly Rodriguez de Bitttner, PharmD, BCPS, CDE, FAPhA
Chair, Department of Pharmaceutical Sciences Paul Shapiro, PhD Chair, Department of Pharmacy Practice and Science Jill Morgan, PharmD, BCPS, BCPPS
BOARD OF VISITORS
Stephen J. Allen, RPh, MS ’78, FASHP, Chair Former CEO, American Society of HealthSystem Pharmacists Foundation Barbara M. Alving, MD, MACP Professor of Medicine, Uniformed Services University of the Health Sciences Research Professor, School of Public Health, University of Maryland, College Park
CENTERS
Bio- and Nano-techology Center Bruce Yu, PhD, Director
John Banta, MBA Managing Director BlueCross BlueShield Venture Partners
Associate Dean for Development and Alumni Affairs Ken Boyden, JD, EdD
Center for Innovative Pharmacy Solutions Magaly Rodriguez de Bittner, PharmD, BCPS, CDE, FAPhA, Executive Director
Harold E. Chappelear, DSC ’98, RPh, LLD (Hon.) Principal, InternaSource, LLC
Associate Dean for Graduate Programs Sarah Michel, PhD
Center for Translational Medicine Joga Gobburu, PhD, MBA, FCP, Director
Associate Dean for Research and Advanced Graduate Studies Peter Swaan, PhD
Center of Excellence in Regulatory Science and Innovation James Polli, PhD, Co-director
Victoria G. Hale, BSP ’83, PhD, DSc (Hon) Founder & Former CEO OneWorld Health Medicines360
Associate Dean for Student Affairs Cherokee Layson-Wolf, PharmD, CGP, BCACP, FAPhA
Center on Drugs and Public Policy Francis B. Palumbo, PhD, JD, Executive Director
Assistant Dean for Academic Affairs and Assessment Lisa Lebovitz, JD
Computer-Aided Drug Design Center Alexander D. MacKerell Jr., PhD, Director Jana Shen, PhD, Co-director
Assistant Dean for Communications and Marketing Rebecca Ceraul
Maryland Poison Center Bruce D. Anderson, PharmD, Director
Assistant Dean for Experiential Learning Agnes Ann Feemster, PharmD, BCPS Assistant Dean for Information Technology Tim Munn Assistant Dean for Instructional Design and Technology Shannon Tucker, MS
32
Chair, Department of Pharmaceutical Health Services Research C. Daniel Mullins, PhD
Mass Spectrometry Center Maureen Kane, PhD, Executive Director Mental Health Program Raymond Love, PharmD, Director Metallotherapeutics Research Center Sarah Michel, PhD, Co-director Angela Wilks, PhD, Co-director
Assistant Dean for Policy and Planning Deborah Dewitt, JD
Peter Lamy Center on Drug Therapy and Aging Nicole Brandt, PharmD, MBA, BCPP, CGP, FASCP, Executive Director
Assistant Dean for the Universities at Shady Grove Heather Brennan Congdon, PharmD, CACP, CDE
Pharmaceutical Research Computing Ebere Onukwugha, PhD, MS, Executive Director
c a p su l e
www.pharmacy.umaryland.edu
Gina McKnight-Smith, PharmD ’97, MBA, CGP, BCPS Regional (Mid-Atlantic) Medical Outcomes Science Liaison AbbVie, Inc. Thomas E. Menighan, BSPharm, MBA, FAPhA Executive Vice President and CEO American Pharmacists Association David W. Miller, PhD ’93 Operating Partner, GHO Capital Ltd. Jane Shaab, MBA Senior Vice President and Executive Director, University of Maryland BioPark Assistant Vice President for Economic Development, University of Maryland, Baltimore Jermaine Smith, RPh Senior Director, Legislative and Regulatory Affairs Rite Aid Pharmacy Ellen H. Yankellow, PharmD ’96, BSP ’73 President and CEO, Correct Rx Pharmacy Services, Inc.
Special thanks to the following contributors: William Cooper, Nicole Derr, Jenny Giller, Greer Griffith, Cherokee Layson-Wolf, and Lisa Lebovitz
KEY FACTS
ACADEMIC PROGRAMS 881
Total enrollment all degree programs
ACADEMIC TRAINING 37
Postdoctoral fellows
22 Residents PHARMD PROGRAM 535
Total enrollment
FACULTY
Fall 2018 admission
90
Full-time faculty
632
Total applicants
115
Affiliate faculty
131
Entering class
698
Preceptor faculty
21%
Acceptance rate
73%
With undergraduate degree or higher
STAFF
3.37
Average incoming GPA
70
Administrative, business, development and alumni
75%
Average PCAT composite percentile rank
affairs, experiential learning, human resources,
communications and marketing, student affairs,
and faculty support
30% White
233
Technical, research staff, postdoctoral fellows,
20% Black
and teaching assistants
Ethnicity across all four years: 39% Asian
5% Hispanic 3% International
SCHOLARLY ACTIVITY
2% Multi-ethnic
144
Principal investigators
1%
419
Refereed works published (authored or co-authored)
129
Non-refereed works published (authored or
No response
Number may not total 100 percent due to rounding
co-authored) PHD PROGRAMS 88
Total enrollment
Department of Pharmaceutical Health Services Research 26 Students
598
Papers presented at professional meetings
PROFESSIONAL SERVICES 16
Review panels (off-campus peer review panels and
accreditation and certification teams)
2,537
Manuscripts read/reviewed for professional journals,
Department of Pharmaceutical Sciences
conferences, and publishers
62 Students
74
Editors/associate editors for professional journals
79
Officeholders of professional associations
MASTER’S PROGRAMS
197
Total days in public service (non-consulting role with
258
K-12 schools and community colleges, government
agencies, nonprofit organizations, or businesses)
Total enrollment
Pharmaceutical Health Services Research 3
Students
Palliative Care 139
Students
PLACEMENT/EMPLOYMENT Job Placements for the PharmD Class of 2018 Data is based on a survey voluntarily completed by graduating students in May.
Pharmaceutical Sciences 6
Students
152
Total Number of Graduates
53
Additional Training (PGY1, Fellowship,
Graduate School)
42
Community Pharmacy, Chain or Independent
Regulatory Science
3
Hospital Pharmacy or Outpatient Health System
56
4
Other (Pharmacy LTC, USPHS, Industry, Federal, etc.)
50
Did Not Respond to Survey or Still Seeking
Pharmacometrics 54
Students
Students
Employment
sp ring 2 0 2 0
33
FINANCIALS
SOURCES OF OPERATING REVENUES SUPPORTING THE SCHOOL This report is an unaudited presentation of revenues supporting the School. Gifts $2,857,660 Grant and Contract Awards and Designated Research Initiative Funds $31,009,213
FISCAL YEAR 2017-2018 Total Source of Funds $68,592,812 Net General Appropriation and Tuition and Fees $29,852,573
Auxiliary and Misc. $2,934,564
Scholarships, Fellowships, and Endowments $1,571,486
Federal Funds $367,316
Gifts $1,354,592
FISCAL YEAR 2016-2017 Total Source of Funds $64,974,543
Grant and Contract Awards and Designated Research Initiative Funds $29,404,062
Net General Appropriation and Tuition and Fees $28,978,016
Auxiliary and Misc. $3,238,792 Federal Funds $367,316
34
c a p su l e
www.pharmacy.umaryland.edu
Scholarships, Fellowships, and Endowments $1,631,764
NEW FACULTY
Daniel Deredge, PhD Research Assistant Professor Department of Pharmaceutical Sciences Born in France, Deredge grew up primarily in Ethiopia where he completed his high school education. In 1999, he came to the United States to attend Louisiana State University in Baton Rouge, where he received both a Bachelor of Science and a PhD in biochemistry. During his graduate studies, Deredge characterized the solution thermodynamic properties of DNA binding by bacterial DNA polymerase I, focusing specifically on the polymerase from E. coli and T. aquaticus and their response to the accumulation of the physiological counter-anion glutamate. Subsequently, Deredge undertook postdoctoral studies at Case Western Reserve University in Cleveland, where he studied the structural origin of resistance of HIV reverse transcriptase to a non-nucleoside reverse transcriptase inhibitor, Efavirenz, applying hydrogen-deuterium exchange coupled with mass spectrometry (HDX-MS). In 2012, he came to the University of Maryland School of Pharmacy to pursue additional postdoctoral training and, as part of the School’s Mass Spectrometry Center, expand the application of HDX-MS, native mass spectrometry and ion mobility, fast photochemical oxidation of proteins to various biological and biophysical systems. His studies include bacterial, viral, and human protein systems studied within the perspective of protein folding, protein dynamics, protein-ligand binding, protein-protein interactions, and protein-nucleic acids interactions. As a research assistant professor, Deredge is developing and applying a framework to correlate experimental HDX-MS with computational approaches to augment the structural and biophysical understanding of various systems.
Ashlee Mattingly, PharmD, BCPS Assistant Professor Department of Pharmacy Practice and Science Mattingly received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in 2011. After graduation, she worked as a pharmacist at Kindred Hospital, a long-term acute care hospital, in Louisville, Ky. In 2013, Mattingly joined Community Hospital South in Indianapolis as a clinical pharmacist. At the University of Maryland School of Pharmacy, Mattingly focuses on sterile and non-sterile compounding and serves as director of the School’s PharmTechX Program, an advanced pharmacy technician
training program. Her research includes the advancement in delivery of patient care through the use of pharmacy technicians, including the potential opportunities and the positive impact this can have on patient outcomes and overall pharmacy technician satisfaction. She also is interested in the regulations surrounding sterile and nonsterile compounding and developing processes that balance public safety with the efficient production of compounded pharmaceutical products. Mattingly has two research grants with the U.S. Food and Drug Administration evaluating the use of bulk drug substances in compounding as outlined in the Drug Quality and Security Act passed in 2013.
Kristine Parbuoni, PharmD, BCPPS Associate Professor Department of Pharmacy Practice and Science Parbuoni obtained her Doctor of Pharmacy from the University of Maryland School of Pharmacy in 2005. She then completed a PGY1 pharmacy residency and PGY2 pediatric residency at Johns Hopkins Hospital in Baltimore. Following residency training, Parbuoni became the clinical pharmacy specialist in the Pediatric Intensive Care Unit at the University of Maryland Children’s Hospital, where she later also took on administrative roles. Parbuoni then joined the faculty at Loma Linda University School of Pharmacy as an assistant professor in the Department of Pharmacy Practice, where she was also director of the PGY2 Pediatric Residency Program. She is a board-certified pediatric pharmacy specialist and maintains a clinical practice site in general pediatrics at the University of Maryland Children’s Hospital. She is also director of the School of Pharmacy’s PGY2 Pediatric Residency. Parbuoni has been actively involved in professional organizations throughout her career. She has served as president of the Maryland Society of Health-System Pharmacy, as a delegate for the American Society of Health-System Pharmacists (ASHP), on ASHP’s Council on Education and Workforce Development and Preceptor Development Section Advisory Group (SAG) and Pediatrics SAG. Parbuoni also was chair of the California Society of Health-System Pharmacists Membership Committee and chair of the Research Committee of the Pediatric Pharmacy Association. Her research interests include clinical outcomes in pediatrics (infectious diseases, critical care), pediatric pharmacokinetics, educational methods and outcomes in simulation, and postgraduate training.
sp ring 2 0 2 0
35
NEW FACULTY
Ryan Pearson, PhD Assistant Professor Department of Pharmaceutical Sciences
Zafar Zafari, PhD, MSc, BSc Assistant Professor Department of Pharmaceutical Health Services Research
Pearson’s research focuses on engineering nanoparticles to achieve programmable immune responses for specific immunomodulation and molecular design to achieve controllable cellular interactions for targeted drug delivery. His lab is focused on developing strategies for treating dysregulated immune responses such as allergy, inflammation, and cancer through the intersection of two enabling disciplines — nanotechnology and immune engineering. As a postdoctoral fellow at the University of Michigan, he championed projects related to nanoparticle engineering and protein delivery for antigenspecific tolerance induction (i.e., autoimmunity, allergens, allogeneic cell transplantation). Notably, he contributed to the invention of CNP-101, an immune tolerance-inducing nanoparticle for the treatment of celiac disease, which has been licensed by Takeda Pharmaceutical Co. As a graduate student at the University of Illinois at Chicago, Pearson worked to synthesize and evaluate novel polymer molecular architectures based on dendrimers and linear-block copolymers. His research led to discoveries that improved the fundamental understanding of nanoparticle-biological interactions and strategies to overcome critical challenges associated with targeted drug delivery. Since 2009, Pearson has published 22 manuscripts in high-impact journals that have been cited more than 800 times. He is an inventor on three patents associated with biomaterials for immunomodulation, and is an active member of the board of directors for the Controlled Release Society ImmunoDelivery Focus Group.
Zafari is a quantitative outcomes researcher with interests in a wide range of applied and theoretical topics in health economics, outcomes research, and health policy, including developing advanced cohort/micro simulation models for cost-effectiveness or comparative effectiveness of health policies or technologies, Bayesian methods of synthesizing and reconciling evidence, statistical methods of longitudinal analyses, prospective, or retrospective studies including multi-level (hierarchical) modeling, age-period-cohort analysis, and non- or semi-parametric modeling to address burning epidemiological and health policy questions. He received a PhD in health economics and outcomes research in 2016 at the University of British Columbia. During his PhD, he worked as a mathematical modeler and data scientist affiliated with the Center for Clinical Epidemiology and Evaluation and as a health economist/epidemiologist for the Center of Collaborations for Outcomes Research and Evaluation. He received a MSc in mathematics from the University of British Columbia in 2012, and a BSc in electrical engineering from Tehran Polytechnic University in Iran in 2010. Zafari was a postdoctoral research scientist in the Department of Health Policy and Management at Columbia University in New York from 2016 to 2018. During this time, in addition to working on a variety of projects on the cost effectiveness of social and preventive policies, he conducted research to quantify and understand the trends of sociological well-being over time and their impact on survival inequalities in the United States.
36
c a p su l e
www.pharmacy.umaryland.edu
GRANT AND CONTRACT AWARDS |
July 1, 2017– June 30, 2018
DEPARTMENT OF PHARMACEUTICAL HEALTH SERVICES RESEARCH (PHSR) PROJECT INVESTIGATOR
RANK/TITLE
PROJECT TITLE
SPONSOR NAME
Associate Professor
Secondment Agreement
BMJ Publishing Group Ltd., Inc.
Peter Doshi Associate Professor
Restoring Invisible and Abandoned Trials Support Center
Laura and John Arnold Foundation $348,404
Susan dosReis Professor
Center for Patient-Focused Value Assessment
Pharmaceutical Research and Manufacturers of America
$223,155
Susan dosReis Professor
State of Maryland Foster Care Psychotropic Database Monitoring
Maryland Department of Human Services
$100,652
Maya Hanna Graduate Student
PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS
Agency for Healthcare Research and Quality
$7,675
Maya Hanna Graduate Student
Geographic Variations of Screening and Diagnosis of Alzheimer’s Disease and Related Dementias in the U.S.
Pharmaceutical Research and Manufacturers of America
$25,000
C. Daniel Mullins Professor and Chair
PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS
Agency for Healthcare Research and Quality
$842,516
C. Daniel Mullins Professor and Chair
Mapping and Resourcing Patient and Stakeholder Engagement Along 10-Step PCOR Continuum Framework
Patient-Centered Outcomes Research Institute
$399,321
C. Daniel Mullins Professor and Chair
Pragmatic Clinical Trials of Proton vs. Photon Therapy for Patients with Breast and Lung Cancer
University of Pennsylvania
$104,385
C. Daniel Mullins
Merck/UMB SOP HEOR Fellowship
Merck & Co. Inc.
$105,073
C. Daniel Mullins Professor and Chair
Patient-Centered Outcomes Research Scientific and Lay Training
Westat Inc.
$213,017
C. Daniel Mullins Professor and Chair
Increasing Patient-Community Capacity to Engage on Quality of Health Care Research and Programs
National Health Council
$12,500
C. Daniel Mullins Professor and Chair
Direct Medical Costs of Alpha-1 Antitrypsin Deficiency in the United States
Alpha-1 Foundation
$157,753
C. Daniel Mullins Professor and Chair
Improving FDA Health Communications University of Maryland, with Older Women Regarding FDA College Park Regulated Products
Peter Doshi
Professor and Chair
PROJECT TOTAL
$90,000
$162,000
sp ring 2 0 2 0
37
GRANT AND CONTRACT AWARDS
Elisabeth Oehrlein Graduate Student
PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS
Agency for Healthcare Research and Quality
$7,657
Ebere Onukwugha Associate Professor
PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS
Agency for Healthcare Research and Quality
$83,195
Ebere Onukwugha Associate Professor
Non-Hodgkins Lymphoma SEER Medicare Proposal: Health Economics and Outcomes Research
Bayer Pharma AG
$150,393
Eleanor Perfetto Professor
Outcome Measures of Hospitalization from Bleeding Events from Anticoagulant Medication Use
Pharmacy Quality Alliance
$16,488
Eleanor Perfetto Professor
An Intensive Introduction to the Science University of Maryland, of Clinical Outcomes Assessment (COA) College Park – A COA Online Continuing Education Series
$74,986
Eleanor Perfetto Professor Hypoglycemic Events Requiring a Hospital Admission or ED Visit Associated with Anti-Hyperglycemic Medications
Pharmacy Quality Alliance
$150,000
Fadia Shaya Professor
Maryland Department of Health
$380,000
Fadia Shaya Professor Substance Abuse Block Grant Amendment
Maryland Department of Health
$72,000
Fadia Shaya Professor
Social Marketing Campaign, Technical Assistance and Evaluation
Maryland Department of Health
$120,000
Fadia Shaya
Social Marketing Campaign Evaluation
Maryland Department of Health
$135,000
Fadia Shaya Professor
Implementation & Evaluation for the Strategic Prevention Framework for Prescription Drugs Initiative
Maryland Department of Health
$320,000
Fadia Shaya Professor
Technical Assistance and Evaluation of the Strategic Prevention Framework Partnership for Success Initiative
Maryland Department of Health
$215,000
Julia Slejko Assistant Professor
SEER-Medicare Study of Health Outcomes and Economics: Multiple Myeloma Supplement
Takeda Pharmaceutical Co. Ltd.
$300,000
38
c a p su l e
Professor
www.pharmacy.umaryland.edu
Evaluation and Technical Assistance Services for the Maryland Substance Abuse Prevention and Treatment Block Grant Prevention Program
GRANT AND CONTRACT AWARDS
Julia Slejko Assistant Professor
Literature Review of Claims-Based Measures for Oral Oncology Drugs
Novartis Pharmaceuticals Corp.
$154,003
Ester Villalonga-Olives Assistant Professor
PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS
Agency for Healthcare Research and Quality
$15,120
Linda Wastila Parke-Davis Chair of Geriatric Pharmacotherapy Linda Wastila Parke-Davis Chair of Geriatric Pharmacotherapy
Statewide Epidemiological Outcomes Workgroup
Maryland Department of Health
$200,000
Shared Savings Calculations
Maryland Health Care Commission $60,385
Linda Wastila Parke-Davis Chair of Geriatric Pharmacotherapy
Novartis HEOR Fellowship
Novartis Pharmaceuticals Corp.
$114,011
Linda Wastila Parke-Davis Chair of Geriatric Pharmacotherapy
Novartis HEOR Fellowship
Novartis Pharmaceuticals Corp.
$109,420
Linda Wastila Parke-Davis Chair of Geriatric Pharmacotherapy
Shared Savings Calculations
Maryland Health Care Commission $65,420
Linda Wastila Parke-Davis Chair of Geriatric Pharmacotherapy
Novartis HEOR Fellowship
Novartis Pharmaceuticals Corp.
$109,420
PHSR Total
$5,643,949
DEPARTMENT OF PHARMACY PRACTICE AND SCIENCE (PPS) PROJECT INVESTIGATOR
RANK/TITLE
Bruce Anderson Professor
PROJECT TITLE
Denver Health and Hospital Authority WO# 34 and 35
SPONSOR NAME
PROJECT TOTAL
Denver Health and Hospital Authority
$27,799
Bruce Anderson Professor State Children’s Health Insurance Program
Maryland Department of Health
$2,824,120
Bruce Anderson Professor
Poison Center Support and Enhancement
Health Resources and Services Administration
$212,188
Bruce Anderson Professor
Enhanced Toxidromic Surveillance Using Poison Center Data
Maryland Department of Health
$70,000
sp ring 2 0 2 0
39
GRANT AND CONTRACT AWARDS
Bruce Anderson
Professor
Naloxone Surveillance Project
Maryland Department of Health
$199,976
Geriatrics Workforce Enhancement Program
Johns Hopkins University School of Medicine
$55,000
Nicole Brandt Professor MedStar Good Samaritan Hospital Service Agreement Nicole Brandt Professor Modernization, Testing & Validation of Alternate Formats of the Medicare Part D MTM Program Standardized Format
Good Samaritan Hospital
$29,934
Academy of Managed Care Pharmacy
$72,645
Nicole Brandt Professor Kimberly Claeys Assistant Professor
Maryland Department of Health
$200,000
Nicole Brandt Professor
Antimicrobial Stewardship in the Post-Acute Long-Term Care Setting
Improving Clinical Outcomes in Gram- MAD-ID: Making a Difference in Negative Bacteremia Through a 24-Hour Infectious Diseases Multidisciplinary Verigene Gram-Negative Blood Culture Treatment Pathway
$27,222
Kimberly Claeys Assistant Professor Comparing the Clinical Utility of Rapid Diagnostics for the Treatment of Bacteremia
Society of Infectious Diseases Pharmacists
$9,039
Catherine Cooke Research Part D Enhanced Medication Therapy Associate Professor Management Technical Implementation Support
IMPAQ International, LLC
$31,104
Catherine Cooke
Maryland Department of Health
$100,000
Research Associate Professor
Fill Status Notification to Improve Hypertension Management
Catherine Cooke Research Associate Professor
PCORI Training for Minority Practitioners Patient-Centered Outcomes and Their Patients: Targeting the Silent Research Institute Killers of Cardiovascular Disease
$187,393
Bethany DiPaula Professor
Springfield Hospital Center – Pharmacy Services
Maryland Department of Health
$1,438,166
Bethany DiPaula Professor
Opioid Prescription Review for Pain Management
Maryland Department of Health
$135,816
Bethany DiPaula
Pharmacy Education Project
Maryland Department of Health
$196,987
Memorandum of Understanding - Prince George’s Hospital Center and University of Maryland, Baltimore
Dimensions Health Corp.
$609,827
FY18-19 Service Addendum #2
Johns Hopkins Hospital
$44,784
Professor
Natalie Eddington Dean and Professor Agnes Ann Feemster Associate Professor
40
c a p su l e
www.pharmacy.umaryland.edu
GRANT AND CONTRACT AWARDS
Agnes Ann Feemster Associate Professor Memorandum of Understanding for Joint Clinical and Educational Collaboration
Johns Hopkins Hospital
$44,236
Joga Gobburu
PK Analysis Plan
Collegium Pharmaceutical
$8,000
Joga Gobburu Professor
Use Pharmacokinetic Data for Modeling and Simulation of Pediatric Drug Trial Design
Sunovion Pharmaceuticals, Inc.
$25,000
Joga Gobburu Professor
New Drug Application Strategy and Modeling and Simulation Support
Upsher-Smith Laboratories, Inc.
$25,000
Joga Gobburu Professor
USL-261 PBPK Modeling and Regulatory Strategy
Proximagen, LLC
$100,000
Mathangi Research Gopalakrishnan Assistant Professor
Pharmacodynamic and Pharmacokinetic Wockhardt Ltd. Properties of Wockhardt’s WCK 9444 with Actraphane 30 and Simultaneous Injections of Lantus & Actrapid in Healthy Subjects
$25,000
Mathangi Research Gopalakrishnan Assistant Professor
A Randomized, Single Center, Double Blind, Two Treatment, Two Period, Crossover Glucose Clamp Study to Test for Bioequivalence between Wockhardt’s Consegna and Mixtard in Healthy Subjects
Wockhardt Ltd.
$25,000
Emily Heil Associate Professor
Society of Infectious Diseases Pharmacotherapy Residency Award
Society of Infectious Diseases Pharmacists
$60,000
Emily Heil Associate Professor
Oral Vancomycin plus Intravenous Metronidazole for Severe Clostridium Difficile NAP1/BI/027 Infection
American Association of Colleges of Pharmacy
$4,564
Emily Heil Associate Professor Clinical Outcomes with Ceftolozane- Tazobactam in Patients with Multi Drug Resistant Pseudomonas aeruginosa Infections Lauren Hynicka Associate Professor Hepatitis C Virus Review Program
Temple University – HSC
$2,997
Maryland Department of Health
$474,579
Vijay Ivaturi Research Assistant Professor Vijay Ivaturi Research Assistant Professor
Pharmacometric Support for a Neuro- Oncology Drug Development Program
Upsher-Smith Laboratories, Inc.
$100,000
A Comparison of Buprenorphine Vs. Morphine in the Treatment of the Neonatal Ab
Thomas Jefferson University
$23,969
Professor
sp ring 2 0 2 0
41
GRANT AND CONTRACT AWARDS
Vijay Ivaturi
Research Assistant Professor
University of Minnesota
$12,888
Cherokee Layson-Wolf
Associate Professor FY18 Resident Training Agreement and Associate Dean
Sharpsburg Pharmacy
$23,461
Cherokee Layson-Wolf Associate Professor FY18 Resident Training Agreement and Associate Dean Raymond Love Professor Potomac Center - Secure Evaluation and Therapeutic Treatment
Whitesell Pharmacy
$23,461
Maryland Department of Health
$164,180
Raymond Love Professor
Eastern Shore Hospital Center – Improving Pharmacy Services
Maryland Department of Health
$419,040
Raymond Love Professor
Spring Grove Hospital Center – Improving Pharmacy Services
Maryland Department of Health
$1,900,810
Raymond Love Professor
Clifton T. Perkins Hospital Center – Improving Pharmacy Services
Maryland Department of Health
$773,134
Raymond Love Professor Raymond Love Professor Raymond Love Professor
Thomas B. Finan Center – Improving Pharmacy Services
Maryland Department of Health
$384,696
MHA – Centralized Administration of Pharmacy Services
Maryland Department of Health
$556,813
Peer to Peer Review for Mental Health Drug Programs - Pediatrics
Maryland Department of Health
$2,400,000
Raymond Love Professor
Antipsychotic Prescription Review Program
Maryland Department of Health
$1,613,755
Ashlee Mattingly Assistant Professor
Clinical Use of Bulk Drug Substances Nominated for Use in Compounding by Outsourcing Facilities
University of Maryland, College Park
$148,114
Joey Mattingly Associate Professor
Engaging an Underserved Patient Community to Inform and Improve Comparative Effectiveness Research for Hepatitis C Treatments
Patient-Centered Outcomes Research Institute
$49,500
Joey Mattingly Associate Professor
A Single-Center Pilot to Measure Self-Reported Health Confidence from an Outpatient Pharmacy Discharge Service and 30-day Readmission Rates
Bristol-Myers Squibb
$74,900
42
c a p su l e
www.pharmacy.umaryland.edu
ESETT Pharmacokinetic- Pharmacodynamic Study
GRANT AND CONTRACT AWARDS
Joey Mattingly Associate Professor
Pharmapreneur: Defining the Role of Entrepreneurialism in Schools of Pharmacy
American Association of Colleges of Pharmacy
$10,000
Mary Lynn McPherson Professor
Union Memorial PGY2 Pain and Palliative Care Residency
Union Memorial Hospital
$63,900
Jill Morgan
Professor and Chair
Medstar Georgetown University
MedStar Health Inc.
$71,020
Jill Morgan
Professor and Chair
IPA Agreement
VA Maryland Health Care System $24,831
Jill Morgan
Professor and Chair
Clinical Pharmacy Services
Maryland Department of Health
$186,668
Jason Noel
Associate Professor
Developmental Disablities Administration Maryland Department of Health
$48,204
PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS
Agency for Healthcare Research and Quality
$7,675
Charmaine Rochester Professor Contraceptive Regulation Implementation: Stakeholder Facilitation
Maryland Department of Health
$10,000
Magaly Rodriguez Professor and FY18 Clinical Pharmacy Services de Bittner Associate Dean
University of Maryland Baltimore Washington Medical Center
$92,581
Magaly Rodriguez Professor and de Bittner Associate Dean
Memorandum of Understanding for Joint Clinical and Educational Collaboration
University of Maryland Baltimore Washington Medical Center
$70,231
Magaly Rodriguez de Bittner
Professor and Associate Dean
Joint Clinical and Educational Collaboration
UM Quality Care Network, LLC
$308,135
Leah Sera
Assistant Professor
MedStar Montgomery Medical Center
MedStar Health Inc.
$76,667
Mona Tsoukleris Professor School Epinephrine Administration: Electronic Database Development Consultation
Maryland Department of Health
$4,000
Total PPS
$16,909,009
Kathleen Pincus Associate Professor
DEPARTMENT OF PHARMACEUTICAL SCIENCES (PSC) PROJECT INVESTIGATOR
RANK/TITLE
Joel Brandis Graduate Student
PROJECT TITLE
Development of Bioanalytical Mass Spectrometric Approaches to Measure Iron Release in Plasma of Patients Treated with IV Iron Preparations
SPONSOR NAME
PROJECT TOTAL
American Foundation for Pharmaceutical Education
$10,000
sp ring 2 0 2 0
43
GRANT AND CONTRACT AWARDS
Andrew Coop
Professor and Associate Dean
Preclinical Identification of Better Antimuscarinic Antidepressants
University of Texas Health Science Center at San Antonio
$91,445
Alecia Dent Graduate Student The Non-Redundant Role of the Has and Phu Heme Acquisition Systems of Pseudomonas aeruginosa in Iron Homeostasis
National Institutes of Health
$29,173
Brandon Drennen Graduate Student Towards a New Therapeutic Modality for the Treatment of Alzheimer’s: Interception of Transient Helical States of beta-Amyloid with Small-Molecule Proteomimetics
American Foundation for Pharmaceutical Education
$10,000
Steven Fletcher Associate Professor
Washington University
$81,790
Steven Fletcher Associate Professor Enhancers of Reverse Cholesterol Transport
Maryland Industrial Partnerships
$68,253
David Goodlett Professor
Functional Characterization of the Bax-Interacting Factor-1 Interactome in Neurons
University of Washington
$18,756
Stephen Hoag Professor
Effect of pH of Smokeless Tobacco Products on the Pharmacokinetics of Nicotine in Current Users
Battelle Memorial Institute
$38,024
Preclinical and Clinical Imaging and Treatment of Multiple Myeloma with cMyc-Max Nanoparticles
Stephen Hoag Professor Professional Service for Manufacturing Food & Drug Administration an in vitro Component of an Assessment of a Proposed in vitro Bioequivalence Approach for Evaluating Generic and New Animal Formulations
$32,000
Stephen Hoag Professor Formulation Development for Rare Disease Therapy Stephen Hoag Professor Methods For Evaluation of Abuse Deterrence Via Smoking And Vaping
Maryland Industrial Partnerships
$68,252
National Institute of Pharmaceutical Technology and Education
$205,000
Lisa Jones Associate Professor
Mechanism of Transcription Regulation by the Mediator
Indiana University
$9,987
Lisa Jones Associate Professor
CAREER: Development of an In Cell Footprinting Method for the Analysis of Protein Structure
National Science Foundation
$219,677
44
c a p su l e
www.pharmacy.umaryland.edu
GRANT AND CONTRACT AWARDS
Lisa Jones Associate Professor
A Novel Protein Footprinting Method Coupled with Mass Spectrometry for the Structural Analysis of Class II CFTR Mutants
Cystic Fibrosis Foundation
$54,000
Lisa Jones Associate Professor
Development of an in vivo Footprinting Method Coupled with Mass Spectrometry in C. elegans
National Institutes of Health
$309,000
Maureen Kane Associate Professor
Molecular Determinants of Retinoid Metabolism in Embryonic Tissues
University of Kansas Center for Research, Inc.
$52,924
Alexander MacKerell Jr. Grollman-Glick Professor
Program for Therapeutic Targeting of Transcriptional Repression
Samuel Waxman Cancer Research Foundation
$15,000
Alexander MacKerell Jr. Grollman-Glick Carbohydrate Force Fields for Professor Structure, Dynamics, and Molecular Recognition
National Institute of General Medical Sciences
$357,085
Alexander MacKerell Jr. Grollman-Glick Professor
Polarizable Force Field for Proteins and Lipids
University of Chicago
$195,840
Alexander MacKerell Jr. Grollman-Glick Professor
Design and Synthesis of Inhibitors of the BTB Domain of BCL6
Joan & Sanford I. Weill Medical College of Cornell University
$239,110
Alexander MacKerell Jr. Grollman-Glick LRRK2 Dimerization and Therapeutic Professor Evaluation
Johns Hopkins University
$60,515
Alexander MacKerell Jr. Grollman-Glick Professor
Pre-Computed Free Energy Maps for Rapid Structure-Based Ligand Design
SilcsBio LLC
$153,610
Alexander MacKerell Jr. Grollman-Glick Professor
Oligonucleotide Conformational Heterogeneity
National Institute of General Medical Sciences
$292,653
Alexander MacKerell Jr. Grollman-Glick Professor
Molecular Characterization and Drug Design Targeting Emerging Pathogenic Bacteria of Pakistan and Development of an Access Application for the Health Care Industry
The National Academies
$51,599
Alexander MacKerell Jr. Grollman-Glick Professor
Biased Agonism and Conformational Heterogeneity of Beta Adrenergic Receptors in Bronchodilation
Thomas Jefferson University
$77,250
National Science Foundation
$150,000
U.S. Army Research Office
$80,000
Sarah Michel
Professor and Non-Classical Zinc Finger Proteins Associate Dean
Sarah Michel Professor and Associate Dean
Bioanalytical Mass Spectroscopic Approaches to Characterize ProteinStabilized Gold Nanoclusters
sp ring 2 0 2 0
45
GRANT AND CONTRACT AWARDS
Amanda Oglesby- Associate Professor Sherrouse
Role of PrrF and PrrH Regulation in Pseudomonas aeruginosa Pathogenesis
National Institute of Allergy and Infectious Diseases
$428,875
Amanda Oglesby- Associate Professor Sherrouse
Metallobiochemistry of Innate Immunity and Bacterial Physiology
Massachusetts Institute of Technology
$114,532
Amanda Oglesby- Associate Professor Sherrouse
Iron Regulation of CF Lung Pathogen Interactions
Cystic Fibrosis Foundation
$108,000
James Polli Shangraw/Noxell Endowed Chair
University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)
University of Maryland, College Park
$410,086
James Polli Shangraw/Noxell Endowed Chair
Evaluation of Metal Ions in Electronic Cigarette Aerosol Condensates and Determination of Their Effects on Oral Keratinocytes
University of Maryland, College Park
$188,610
James Polli Shangraw/Noxell Endowed Chair
Development and Validation of a Clinically Relevant in vitro Dissolution Test for the Poorly Soluble, Weakly Basic Drug Itraconazole in Spray-Dried Amorphous Solid Dispersion
National Institute of Pharmaceutical Technology
$750,000
C.S. Raman Associate Professor Jana Shen Professor
Redox Biochemistry of Energy Conservation in Methanogens and Their Syntrophic Partners
U.S. Department of Energy
$196,302
Thin Film Biofabrication for Integrated Bio-Electronics
University of Maryland, College Park
$80,000
Jana Shen Professor
Molecular Mechanisms of Secondary Active Transporters
Arizona State University
$73,681
Jana Shen Professor
Electrostatic Modulation of Protein Dynamics and Interactions
National Institute of General Medical Sciences
$347,625
Audra Stinchcomb Professor Bioequivalence of Topical Drug Products: in vitro - in vivo Correlations
Food & Drug Administration
$499,999
Audra Stinchcomb Professor
Heat Effect on Generic Transdermal Drug Delivery Systems
Food & Drug Administration
$499,999
Peter Swaan
Structural Biology of the Apical Bile Acid Transporter
National Institute of Diabetes & Digestive & Kidney Diseases
$350,326
Function and Regulation of SLC13A5 in the Liver
National Institute of General Medical Sciences
$297,413
Professor and Associate Dean
Hongbing Wang Professor
46
c a p su l e
www.pharmacy.umaryland.edu
GRANT AND CONTRACT AWARDS
Hongbing Wang Professor
Developing DL5016 as a Sensitizer for Cyclophosphamide-Based Treatment for Non-Hodgkins Lymphoma
Maryland Technology Development Corp.
$115,000
Angela Wilks Isaac E. Emerson Mechanistic Characterization and Professor Regulation of the Non-Redundant phu and has Heme Uptake Systems of Pseudomonas aeruginosa
National Institute of Allergy and Infectious Diseases
$396,890
Patrick Wintrode Associate Professor Mechanisms of Glycosaminoglycan- Catalyzed Protease Inactivation by Serpins
Vanderbilt University Medical Center
$55,085
Bruce Yu Professor Contact-Free Real-Time In-Line PAT or Continuous Biomanufacturing
National Institute for $197,960 Innovation in Manufacturing Biopharmaceuticals
PSC Total
$8,081,326
Department of Pharmaceutical Health Services Research (PHSR)
$5,643,949
Department of Pharmacy Practice and Science (PPS)
$16,909,009
Department of Pharmaceutical Sciences (PSC)
$8,081,326
Grand Total
$30,634,284
sp ring 2 0 2 0
47
HONOR ROLL OF DONORS |
July 1, 2017 – June 30, 2018
Loyal donors provide the foundation for the School of Pharmacy’s success. Thank you to everyone — our alumni, faculty, staff, and friends — who has invested in the University of Maryland School of Pharmacy. LEGACY COUNCIL The Legacy Council of the University of Maryland acknowledges those who have made generous contributions to the School of Pharmacy through their estate plans. Anyone who has made such a gift is eligible for membership in the Legacy Council. To qualify, simply provide the School of Pharmacy’s Office of Development and Alumni Affairs with documentation of the gift or a copy of the relevant document in which the School is named as a beneficiary (www.umbfplannedgiving.org). For additional information about membership in the Legacy Council and estate planning, please contact the Office of Development and Alumni Affairs at 410-706-5893 or email ggriffith@rx.umaryland.edu. Members of the Legacy Council are: John H. Balch, BSP ’68 Roslyn F. Balch Thomas S. Brenner, BSP ’72 Barry M. Bress, BSP ’79 Theresa A. Bress Gary G. Buterbaugh, PhD Phyllis Brill Wingrat, BSP ’50= Billie Chappelear Harold E. Chappelear, DSc ’98 Gerald I. Cohen, BSP ’58=
Irwin R. Cohen= Kristine W. Ellinger, BSP ’77= Estate of Evelyn Grollman Glick Nancy Rose Harmon= Ilene Harris, BSP ’81, PharmD ’83 Gwynne L. Horwits Leonard Horwits, BSP ’60 George H. Huber, BSP ’61 Sophia Kallelis= Theodore S. Kallelis, PhD ’57=
Dolores H. Kinnard William J. Kinnard Jr., PhD Bernhard Lamy Gregory J. Lukaszczyk, BSP ’84 Estate of Bertha J. Manchey Estate of Helen Mendelsohn David G. Miller, BSP ’85 Joseph H. Morton, BSP ’60= Paul A. Pumpian, BSP ’50= Michael B. Rodell, BSP ’58
Chris A. Rodowskas, PhG ’29= Matthew Shimoda, PharmD ’84 Estate of Lillian K. Slama Allen Spak, BSP ’63= James M. Trattner, PhD ’28= Clayton L. Warrington, BSP ’58 Elizabeth Warrington William J. Zimmerman, BSP ’70 = Signifies Deceased
DAVID STEWART ASSOCIATES In the mid-1980s, several dedicated alumni and friends established a premier giving society, the David Stewart Associates (DSA), to fund Schoolwide initiatives that would propel the University of Maryland School of Pharmacy nationally as a leader in pharmacy education. This leadership giving society honors David Stewart, America’s first professor of pharmacy and a founder of the University of Maryland School of Pharmacy, who symbolized a passion for excellence and commitment to pharmacy education. The founding members of the DSA are: Elwin Alpern, BSP ’51=
Mayer Handelman, BSP ’54
Martin B. Mintz, PD, BSP ’65
Arthur N. Riley, BSP ’70, MS ’72
Leon R. Catlett, BSP ’65
William M. Heller, MS ’51,
Benjamin S. Mulitz
Gerald M. Rosen
Melvin S. Cohen=
PhD ’55, DSC ’87
Elizabeth Newcomb, BSP ’68
David M. Russo, BSP ’79
James P. Cragg Jr., BSP ’43=
H. Elinor Hens=
John R. Newcomb Jr., BSP ’67
Ralph A. Small Jr., BSP ’74
Leonard J. DeMino=
Leon Jablon=
Anthony G. Padussis, BSP ’44=
Arnold Smolen
Donald O. Fedder, BSP ’50=
William J. Kinnard Jr.
David Pearlman, BSP ’52
Bernard A. Weisman, BSP ’70=
Michaeline R. Fedder
Dorothy Levi, BSP ’70
William L. Pearlman, BSP ’48=
Kenneth P. Whittemore Jr.,
Robert Foer, BSP ’51=
Mark A. Levi, PD, BSP ’70
Thomas S. Petr, BSP ’74
BSP ’76
Henry J. Glaser Jr.=
Samuel Lichter, BSP ’60
Stephen J. Provenza, PhG ’29=
Leonard Winkleman
Evelyn Grollman Glick=
Nicholas C. Lykos, BSP ’52=
Lawrence R. Rachuba=
= Signifies Deceased
This core group of philanthropists has inspired other donors to follow their lead. Today DSA membership has grown to create a solid base of private support for the School’s efforts to advance pharmaceutical education, practice, and science. To join this prestigious group of alumni and friends, or for more information on giving to the School, please contact the Office of Development and Alumni Affairs at 410-706-5893 or email ggriffith@rx.umaryland.edu. 48
c a p su l e
www.pharmacy.umaryland.edu
HONOR ROLL OF DONORS
The University of Maryland School of Pharmacy appreciates the financial support of the following individuals and organizations during the period July 1, 2017, to June 30, 2018. GIVING BY INDIVIDUALS
Julian M. Friedman, BSP '56*
Gerolyn Ann Whittemore~
Mark H. Masich
Mary Therese Gyi, BSP '83,
Kenneth P. Whittemore Jr.,
Lisa M. Matson, BSP '88*
David Stewart Associates
Jason M. Noel~
Over $500,000
Ilene Harris, BSP '81, PharmD ’83~
Alice A. Williams, PharmD '12~
Eberechukwu Onukwugha~
Ellen H. Yankellow, BSP ’73,
William M. Heller, MS ’51
Carol Ann Williams~
Glenda S. Owens, BSP ’76~
Robert W. Henderson, BSP ’63*
Thomas G. Williams Jr.,
Kimberly M. Palasik, BSP '88
Walter J. Hryszko, BSP '74*
Raymond A. Palasik, BSP '88
PharmD ’96*
PharmD '06*
BSP '76*
PharmD '06~
$100,000 - $499,999
Maureen Kane
Hannah Jones
Jonathan Kang
Dean’s Club
Doris M. Peng, MS '78
David H. Jones, BSP ‘70~
David A. Knapp*
$500 - $999
Shelby D. Reed, BSP '93, PhD '99
Jill R. Molofsky, BSP ‘81*
Deanne E. Knapp*
Lauren Barbour, PharmD ’16
Bruce D. Roffé, MS '78~
James P. Tristani, BSP ’73*
Calvin H. Knowlton, PhD '93~
Marie Boyden
Pritesh K. Shah, PharmD '01
Raymond C. Love, PharmD '77*
Michelle M. Ceng, PharmD '98*
Julia F. Slejko~
$10,000 - $24,999
Michael Luzuriaga, BSP '70*
Rebecca Ceraul~
Frances Spaven, PhD '86*
Beverly L. Crovo~
Daniel Z. Mansour, PharmD '06~
Lisa Calvert Chalk
Kerry Spaven~
Thomas L. Crovo~
Alexander D. MacKerell Jr.~
Youjin Chang, PharmD '13
Craig K. Svensson, PharmD '81*
Martin B. Mintz, BSP '65*+
David D. Christ, BSP '79*
Susan Svensson
$5,000 - $9,999
Jill A. Morgan~
David P. Cline, PhD '03
George W. Swope Jr., BSP '70
Thomas S. Brenner, BSP ‘72*
C. Daniel Mullins*
Nicholas Cornias, BSP '92*
Jia-Bei Wang, PhD '92~
Jogarao Gobburu
Thomas S. Petr, BSP '74*
Surabhi Y. Dangi-Garimella,
Junling Wang, MS '04, PhD '05
Andrew V. Phan, PharmD ’13
Angela Wilks~
$1,000 - $4,999
Casey Phan
Mary David
Gary J. Wirth, BSP '79
Barbara Alving~
Keith S. Pozanek, BSP '86*
Joseph A. Demino, BSP '84
Loreen A. Wutoh, BSP '86*
Carl Alving~
Arthur N. Riley, BSP '70, MS '72
Leslie D. Frank, BSP '77, PhD '82
Richard L. Wynn, BSP '64,
Andrew Bartilucci, PhD '53*
Jane M. Shaab
Tushar S. Garimella, PhD '05
Christopher M. Blanchette,
Marilyn Shangraw*
Mark D. Gately
Candice Yong, PhD '15
Paul Shapiro~
Andrew Glorioso, BSP '72
Kenneth Boyden~
Elias Shaya
Yara K. Haddad, PharmD '10
Apothecary Club
Cynthia J. Boyle, PharmD '96~
Fadia T. Shaya
Barry D. Hecht, BSP '73
$250 - $499
James L. Bresette, PharmD '97*
Jeffrey B. Sherr, BSP '78*
Alice H. Hill, PharmD ’93*
Stephen J. Allen, MS '78~
Yale H. Caplan, BSP ’63, PhD ’68*
Joanne H. Sherr, BSP '78*
R. Gary Hollenbeck
Wendy Allen~
Suzanne J. Caplan, BSP ’65
Lisa A. Shipley, PhD ’86
Brian M. Hose, PharmD '06~
Marsha E. Alvarez, BSP '71,
Andrew Coop*
Gisele M. Sidbury, PharmD '97~
Stacey Hose~
William J. Cooper*
Larry E. Small, MS '76, PhD ’80*
Karen M. Kabat, MS '83*
Bruce Anderson~
Conrad Peter Dorn Jr., BSP '58
Edward A. Taylor, PharmD '06~
Hee S. Kim, BSP '90
Laurine A. Barrow-Wilson,
Susan C. dosReis, PhD ’99~
Jackie Tran, PharmD ’13
Wendy Klein-Schwartz,
Natalie D. Eddington, PhD ’89*
Melike G. Tunc, PharmD '08
Sherry N. Berlin, BSP '74*
Ira L. Fedder, PharmD '79~
Pinar Tunc
Lisa T. Kloch, BSP '80
Howard K. Besner, BSP '78*
Michaeline R. Fedder
Zeynep T. Tunc, PharmD '06
Stephen C. Kloch, BSP '80*
Charles R. Bonapace, PharmD '97*
J. Philip Fink, BSP '79*
Angelo C. Voxakis, BSP '71*
Kan Chan Ku, PharmD '01
Luke Brewer
Mark G. Fletcher, BSP ’78, MS ’81,
Clayton L. Warrington, BSP ’58*
Suneel Kudaravalli, PharmD '00~
Harold Chappelear, LLD (Hon) ’98~
Elizabeth Warrington~
Neil B. Leikach, BSP '92*
Barbara S. Chong, PharmD '97~
PhD '07
PhD ’83
* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years
Neha Pandit
PhD '05
PharmD '77*
+ Signifies David Stewart Associates Founding Member = Signifies Deceased
PhD '70*
PharmD ’96*
BSP '89~
sp ring 2 0 2 0
49
HONOR ROLL OF DONORS
Tatiana Claro da Silva, PhD '11
Loc K. Dang, BSP '82~
Gayle C. Howell, BSP '91~
Terrence Clemmons, MS '15
Century Club
Daniel A. Diggins Jr., BSP '85
Helen Hsiao, PharmD '06~
James M. Crable, BSP '82~
$100 - $249
Bethany A. DiPaula, PharmD '95
Ronald W. Huffman
Pamela M. Crowe~
Stephanie L. Agelopas, BSP '83
Peter Doshi
Lauren M. Hynicka
Ramesh Dandu, PhD '08
Omoniyi A. Agunbiade,
Dongyi Du, PhD '09~
Vijay Ivaturi
Terry L. Davis, BSP '83,
Ping Jin Du
Cindy Q. Jiang, BSP '90~
Jung Akiyama, PharmD '00
Michelle L. Eby, PharmD '99~
Hao Jiang~
Colleen Day~
Fernando Andrickson, PharmD '08
Donald B. Elliott, BSP '57*
Sophia L. Johnson
Omolola O. Elliott, BSP '92
Yndiana Tineo Andrickson,
Lily Chua Eng, BSP '76
Tali M. Johnson, PharmD '02~
William T. Foley Jr., BSP '58*
Susan M. Evans, BSP '91~
Angel N. Jordan, PharmD '06
Gregory P. Honshul, BSP '75
Clarence L. Anstine, BSP '58~
Daniel A. Farney, PharmD '01~
Patrick Y. Kamara, PharmD '98~
Charise S. Kasser, BSP '83*
Daniel Ashby
Margaret R. Ferguson
Erika L. Kammer, PharmD '08
Jonathan N. Latham, PharmD '98*
Theophilus E. Awuah, PharmD '00
Herbert Friedman, BSP '50~
Susan A. Katz, BSP '88*
Lisa Lebovitz~
Dov E. Banks~
Joyce Friedman
Thomas H. Keller Jr., BSP '63*
Ashlee Mattingly
Freddy E. Banks, BSP '92~
Stephen S. Friedman, BSP '82
Lauretta A. Kerr, BSP ’86
Joey Mattingly, PhD '18
Marshal Banks~
Denise Fu, PharmD '10
Yelee Y. Kim, PharmD '01~
Maura P. Murphy, PhD '99~
Rochelle Banks~
Stephen J. Gandel, BSP '62~
Nelson E. Kline, BSP '92
Sai C. Nimmagadda, PharmD '12~
Robin L. Becker, BSP '84~
Florence F. K. Gee, BSP '74*
William Knebel, PharmD '97
Barbara B. Nussbaum, BSP '89~
Vahram Bedrossian, BSP '79
Maria A. Giannas, PharmD '00
Michael J. Kopcho, MS '62
Kristine Rapan Parbuoni,
Phyllis A. Bernard, BSP '88*
Donald J. Glenn, BSP '83*
Lawrence J. Kotey, PharmD '03~
Thomas J. Biles, PharmD '98~
Brian J. Goetz, PharmD '94*
Julie A. Kreyenbuhl, PhD '99
Eleanor M. Perfetto
Barry L. Bloom, BSP '66*
Mathangi Gopalakrishnan
Edmond J. Kucharski, BSP '84*
Thomas J. Pfaff, BSP '85*
Renan A. Bonnel, PharmD '83
Sarah Grebow
Kathrin C. Kucharski, PharmD '87*
Bonnie L. Pitt, BSP '74~
Stephen P. Boykin, BSP '73,
Greer Griffith
Thomas P. LaMartina, BSP '87*
Jingjing Qian, PhD '12
Deborah F. Groleau~
Kaysha R. Lancaster, PharmD '00~
Pamela N. Roberto, MS '15
John E. Braaten, BSP '79*
George E. Groleau, BSP '76~
Kirk K. Lancaster~
Michael B. Rodell, BSP '58*
Nicole J. Brandt, PharmD '97~
Alicia M. Gronseth, PharmD '11
Ronald E. Lay, BSP '78*
Thomas H. Root, PharmD '00
Robert P. Brauner, BSP '65~
Anthony A. Guerra, PharmD '97
Lisa C. LeGette, BSP '92*
James R. Salmons, BSP '89
Becky A. Briesacher, PhD '01
Joseph G. Handelman, BSP '60
Colleen C. Lehmann, BSP '78~
Sorell L. Schwartz, BSP '59
Elaine L. Brogan, BSP '78*
Sandy Harriman
Henry M. Levi, BSP '63*
Suzanne K. Simala, BSP '84*
Huong T. Bui Dang, BSP '82~
Diana P. Henzel, BSP '93*
Bonnie Levin, BSP '78
Kara J. Sink, BSP '92*
Wendy Camelo-Castillo
Laura J. Herb
Norman L. Levin, BSP '57
Tye D. Souders, PharmD '13
Linda W. Canady, PharmD '06
Mary-Therese Hewins, BSP '81,
Julie E. Limric, BSP '69*
Marc Taraban
Marian L. Cascio, BSP '77*
Dale E. Lintner Jr.
Andrea B. Weiss, BSP ’89*
Jason F. Chancey, PharmD '00*
Frederick M. Hindman, PharmD '17
Denise Lupo Lutz, BSP '77*
Fred M. Weiss, BSP '70*
Juliana Lee Chau, BSP '79
Miriam Kamanitz Hirsch, BSP '76
Frederick J. Mack, BSP '79*
Robert Wixson
Viktor Chirikov, MS ’15, PhD ’15
Stephen W. Hoag~
Walter P. Mackay, BSP '62*
Bay-Mao B. Wu, PharmD '01*
Catherine L. Cioffi, PhD '88~
G. Lawrence Hogue, BSP '69
Daniel F. Mackley, BSP '76*
William Yeboah, PharmD '00*
Arnold E. Clayman, BSP '73*
Kellie Hom
Harry E. Macks, BSP '59~
David M. Yoder, PharmD '98*
Wendy Cohan~
Gwynne L. Horwits*
Jeanne Macks
Susan Cohen-Pessah, BSP '78
Leonard Horwits, BSP '60*
Lawrence L. Martin, BSP '66*
Kimberly Anne Compton, BSP '94
Tamara Howard, BSP '88,
Carolyn S. Mason, BSP '84
David A. Custer, BSP '73*
Edward T. McCagh Jr., BSP '75*
Hedy J. Cylus Gleiman, BSP '73*
Forest S. Howell, BSP '87*
PharmD '98*
PharmD '05~
50
c a p su l e
PharmD '06
PharmD '08
MS ’76~
www.pharmacy.umaryland.edu
MS '84*
PharmD '01
* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years
Kevin F. McCarthy, BSP '80*
+ Signifies David Stewart Associates Founding Member = Signifies Deceased
HONOR ROLL OF DONORS
Gina Patrice McKnight-Smith,
Michael J. Steinberg, PharmD '00*
Abimbola O. Adebowale,
Nicole Caprio, PharmD '16
Jae Hyung Carpenter, PharmD '98
Alan R. Stoff, BSP '70*
Rachel L. Melnick, PharmD '11~
PharmD '97*
Kathryn M. Strong, PharmD '97
Asmita Adhikari
Deborah G. Carroll, BSP '72
Steven J. Miller, MS '87*
Donald W. Taylor, BSP '69~
Mary Afrane, PharmD '15
Jennifer L. Carroll, BSP '92
Yvonne K. Molotsi, PharmD '02*
Nancy L. Taylor, BSP '62*
Lawrence Aiken, BSP '73*
Malissa Carroll
Kathleen M. Morneau, PharmD '11
Sheryl E. Thedford, PharmD '11~
Clement O. Akogyeram,
Joy Y. Chai, PharmD '12
John M. Motsko Jr., BSP '69
Terri A. Thompson Cathers,
William C. Charles, PharmD '11
Arinzechukwu P. Nwanokwai,
Husam A. Albarmawi, MS '16
Andrew Chayasriwong,
Francis J. Tinney, PhD '66*
Kirk N. Alexander, BSP '75
Dora M. Ober, PharmD '90~
Mary J. Tooey
Nichole D. Althouse, PharmD '13
Hansong Chen, PharmD '13
Joseph D. Ober, PharmD ’85*
Denise P. Toyer-McKan,
Burton A. Amernick
Marvin J. Chertkoff, BSP '51,
Joseph Pariser, BSP '63
Alan W. Anthony, PharmD '04
Sharon K. Park, PharmD '04~
Thanh T. Tran, BSP '90~
Caroline T. Bader, BSP '81*
Jennifer A. Cho, PharmD '14
Angela M. Parker, BSP '95*
Tracy R. Travers, BSP '95
Janice Baer
Deborah S. Chou
Lynn M. Perry
Mona L. Tsoukleris, PharmD '87
Marc Baer
Kenneth E. Cohen
Philip M. Perry, BSP '74*
Shannon R. Tucker
Ingrid R. Baramki, MS '63*
Michael J. Cohen, BSP '66*
Anthony J. Petralia Sr., BSP '52*
Anthony O. Uwadia, PharmD '11
Donna M. Barrett, BSP '77
Dana S. Corn, BSP '70*
Carolyn Petralia, PharmD '03*
Joseph E. Vandigo, MS '15, PhD '18
William H. Batt, BSP '63*
Ryan Costantino, MS '19
Judith A. Porter
Donna E. VanWie, BSP '87
Michael G. Beatrice, PhD '01
Brittany C. Couto, PharmD '16
Rana Rais, PhD '10
Wayne D. VanWie, BSP '88*
John A. Beckman, BSP '76
Randy L. Crispin, BSP '79
Lois A. Reynolds, PharmD '01~
George C. Voxakis, BSP '58,
Katherine P. Benderev, BSP '77,
Eric E. Daniels, MS '17
James R. Ritchie, BSP '63*
David G. Danziger, BSP '51
Howard L. Robinson Jr.,
Hongbing Wang~
Alvin M. Blitz, BSP '67
Robert J. Davis Sr., PharmD '78
PharmD '15
PharmD '00~
PharmD '97
PharmD '98
PharmD ’96*
PhD '99~
PharmD '97
PharmD ’79~
PharmD '19
MS ’54~
Yanhong Wang
Susan C. Bloom
Pamela E. Deiss, BSP '85
Magaly Rodriguez de Bittner,
Linda Wastila~
Thomas V. Bolling, BSP '69*
Mary Eckert DeLuca, BSP '79*
Fran Weiskopf, PharmD '88*
Curtis A. Bowen, BSP '56*
Alecia Dent
Joseph M. Ruppel, BSP '75*
PharmD '83*
Andrew Wherley, PharmD '19
Laura M. Bozzi, MS '14
Christopher W. Dobroth,
Lisa Coppolo Ruppel, PharmD '90
Emily S. Wiener, PharmD '15
Lynette R. Bradley-Baker, BSP '92,
Laura E. Sampson, BSP '87
Fengtian Xue
John P. Dolan, PharmD '14
Brian L. Schumer, BSP '81*
Hawyee T. Yan, BSP '83
Toni Brafa-Fooksman
Charles R. Downs, BSP '73,
Mark W. Sellers, PharmD '03
Irvin Yospa, BSP '61*
Joel Brandis
Steven B. Shannon, PharmD '11
Donald R. Young, BSP '57*
Patrick K. Brannen, PharmD '99
Patricia E. Draper, BSP '83
Stuart Shapiro
Y. Bruce Yu
Jeffrey M. Brewer, PharmD '98
Nancy A. Dravis, BSP '81
Christopher L. Shawyer, BSP '76*
William V. Zappa, BSP '74*
Margaret C. Brophy, BSP '77
Norman DuBois, BSP '53*
Yan Shu
Gene G. Zepp, BSP '48~
Roberta L. Brown, PharmD '80
Erin S. Dudley, PharmD '09
John C. Smith, BSP '76*
Reid A. Zimmer, BSP '63*
Marian C. Bruce
Kathleen E. Dury
Stephen L. Buckner, BSP '67
Sharon I. Early, PharmD '97
Judith Wenzel Smith, BSP '77*
PhD '99*
PharmD '15
PharmD ’99*
Larry A. Snyder, BSP '60*
Contributions up to $99
Jennifer T. Bui, PharmD '89
Jasmine M. Ebron, PharmD '16
Rona S. Snyder*
Cordelia N. Abazie, PharmD '05
Leslie J. Burgess, PharmD '03
Hillary A. Edwards
Adams O. Solola, PharmD '04
Jennifer A. Abernathy, PharmD '13
Michael A. Burns, BSP '88
Odera I. Ekwunife, PharmD ’19
Kaitlyn M. Solola, PharmD '04
Lawrence M. Abrams, BSP '55*
Melanie Byrd
Rodney Elliott
Nina H. Spiller, PharmD '88*
Dennis M. Ackerman, BSP '70*
Martin J. Calabrese
Michael J. Evanko Jr., BSP '73
Molrat Sripinyo, BSP '83*
Marie V. Adams~
Dianna L. Campbell, PharmD '16
Karla D. Evans, BSP '93
Charles H. Steg Jr., BSP '78
Robert W. Adams, BSP '68*
Stanley Caplan, BSP '70
Cheryl Fahlman, PhD '03
* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years
+ Signifies David Stewart Associates Founding Member = Signifies Deceased
sp ring 2 0 2 0
51
HONOR ROLL OF DONORS
Jill R. Fetter, BSP '93*
Lori A. Hollis, PharmD '92
Elizabeth Klutts
Janet L. Mighty, BSP '82~
Robert D. Fetter
Paul Holly
Charles J. Kokoski, BSP '51,
Margaret Miklich
Jerome L. Fine, BSP '56,
Kyungwan Hong
Harris L. Miller, BSP '65*
PharmD ’96
MS ‘53, PhD '56*
Yoon Duk Hong, PharmD '17
Diana J. Kozuch
Jennifer Miller
Lisa Finn
Ronald M. Hopkins, BSP '63
Patricia Kpolie
Matthew Mills
Robyn E. Firmin, PharmD '17
Arley Hunter, PharmD '09
Lawrence J. Krebs, PharmD '06
Kellie M. Monzillo, PharmD '06
Melissa G. Fiscus, PharmD '17
Nigel Roger Isaacs, PharmD '93~
Aida E. Kuzucan, PharmD '15
Steven Monzillo
Devon M. Flynn, PharmD '05
Anthony M. Ishak, PharmD '02
Olayinka Ladeji
Karen Morales
Jack H. Freedman, BSP '70
Jeanine E. Jackson, PharmD '05
Angela Lamy
Thomas L. Morgan, BSP '93*
Erin P. Freeman, PharmD '14
Paul F. Jarosinski, BSP '76
Mark H. Lapouraille, BSP '84
Jeffrey S. Mrowczynski,
Paul Freiman, BSP '53~
Clarence A. Jeffers III, BSP '75
Ivy I. Laryea-Akogyeram,
Phyllis Freiman~
Abree Johnson
Elizabeth S. Murias, BSP '84
Jack Frieman, BSP '56
Lisa M. Johnson-Pope,
Stephen L. Lauer, BSP '62
Hyung J. Na, BSP '89
Adele Fu
Cherokee L. Layson-Wolf,
Paul J. Na, BSP '90
Priyanka Gaitonde, MS '16,
Jace Jones
Nabil Natafgi
PhD '18
PharmD '99
BSP '93~
PharmD '00~
PharmD '13~
Lisa Jones
Calvin Y. Lee, PharmD '04
Barbrakaryne N. Nchinda Fobi,
Aakash Bipin Gandhi
Louis M. Jones, PharmD '09
Richard Lee
Ankit Gandhi, PharmD '19
Michael E. Jones, BSP '72*
Yoon-Hee C. Lee, PharmD '02
Katherine E. Nelson, PharmD '12
Thelma R. Ganser
John T. Jordan Jr., PharmD '95
Joseph H. Lerner, BSP '60
Heather Neu
Patricia H. Gaskin, BSP '58
Susan E. Jordan, BSP '94
Melvin Lessing, BSP '66*
Kwabena O. Nimarko,
Stephen M. Gerardi, BSP '75
Teny Joseph, PharmD '19
Dorothy Levi, BSP '70
Doris Titus Glover
Carl Kaiser, MS '52, BSP ’53,
Siyun Liao, PharmD '11
Heather A. Nizer, PharmD '96
Jeffrey Gonzales
Susana Mourino Lopez
Andongfac Nkobena, PharmD '16
Bruce M. Gordon, BSP '79,
Angela M. Kaitis, BSP '75,
Daniel C. Lyons, PharmD '07~
Chidubem N. Nwankwo,
Gary H. Magnus, BSP '81
PharmD '82
PhD '55* PharmD ’06~
PharmD '15
PharmD '17
PharmD '01
Emily F. Gorman
Beatrice A. Kallungal, MS '15
Ann G. Mantelmacher, BSP '80
Naitia M. Nwatu, PharmD '15
Lee H. Gradman, BSP '57
Rachna Kapoor, PharmD '05
Clifford W. Mason, PhD '08
Elisabeth Oehrlein, PhD '18
Frances A. Gray, PharmD '13
Robert Karrs
Nachi A. Mbinkar, PharmD '13
Amanda Oglesby-Sherrouse
Martin D. Grebow, BSP '60*
Trinh Michelle Keelin,
David J. McCaffrey III, BSP '90
Ihuoma U. Onyewuchi,
Laura Gressler
Madeline McCarren, PhD '83~
Julie Lynne Groff
Dianna N. Kenner-Staves,
Matthew E. McGovern, BSP '91~
Eleanor A. O'Rangers,
Shauna D. Guest
Earl A. McLaren, BSP '89
Stephanie Hale, PharmD '08
Tsedeke Ketema
Alexandra L. McPherson,
Mary E. Ortiz, BSP '87*
Whitney N. Hanson, PharmD ’10
Eric Kettering
Robin L. Paluskievicz,
Jeffrey J. Harnsberger, BSP '92~
Lena Kim, PharmD '18
Mary Lynn McPherson,
Ann Harris
Stonewall C. King Jr., MS '60
Si Yeon Park
Lois T. Havranek, BSP '60~
Hellen N. Kiruthi, PharmD '02
Lori Ann Mears, BSP '82
Ha K. Phan, PharmD '17
Mojdeh Heavner, PharmD '08
Kathryn Kiser
Erin Merino
Dominique N. Phelps, BSP '86
Carl L. Heifetz, BSP '57
Eliford N. Kitabi
Stanley J. Merwitz, BSP '54*
Deborah J. Pippin, PharmD '06
Sandra Heifetz
Ronald P. Kleiman, BSP '82
Jonathan A. Meyer, PharmD '17
Cristina V. Platon, BSP '83*
Emily Heil
Barbara Klein
Wayne M. Meyers
Marvin S. Platt, BSP '51*
Geoffrey A. Heinzl, PhD '16
Linda C. Klein, BSP '72*
Sara K. Meyers-Clark, BSP '91
James Polli
Bernard P. Heyman, BSP '57~
Kathleen Klemm, PharmD '08~
Sarah L. Michel
Stuart L. Porter
52
c a p su l e
PharmD '02 PharmD '16
www.pharmacy.umaryland.edu
PharmD '15 PharmD '86*
* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years
PharmD ’16 PharmD ’90
PharmD '98*
+ Signifies David Stewart Associates Founding Member = Signifies Deceased
HONOR ROLL OF DONORS
Apoorva Pradhan
Arvin P. Shroff, PhD '62
Yunga Vercelline, BSP '93
Carl Kaiser, BSP
Bryan P. Prazak, PharmD '06
Stephanie E. Shulder, PharmD '15
Ester Villalonga Olives
Charles J. Kokoski, MS
Julie Preis, PharmD '99
Jan Sieluk, PhD '18
Lisa A. Vuolo
Jordan Pritts
Harriet Silverstein~
Reenie T. Wagner
Class of 1954
Danya Qato
Morton I. Silverstein, BSP '54*
Andrew J. Walker
Marvin J. Chertkoff, MS
Kimberly Raines-Isler, PhD '06
Cheryl Simmons-Gray,
Mary Walter
Stanley J. Merwitz, BSP
Sangeeta V. Raje, PhD '02~
James C. Wang, PharmD '11~
Morton I. Silverstein, BSP
Kumaran Ramakrishnan,
Matthew O. Siuta, PharmD ’11
Mingxiang Wang, PharmD '13
Meagan C. Small, PhD '15
Allie Wasik
Class of 1955
Budne C. Reinke, BSP '63*
Olufunke Sokan
Brenda K. Weller, BSP '92*
Lawrence M. Abrams, BSP
Luann Orehek Reno, BSP '89~
Jerry A. Solomon
Charles T. Wells III, PharmD '01
Carl Kaiser, PhD
Blair M. Robinson
O'Mareen Spence
Monica L. White, PharmD '95~
David J. Seff, BSP
Elizabeth Robinson
Kathleen J. Sremcich,
Liyi Wu
Milton F. Toelle, BSP
Gertrude M. Robinson
Sharyn Yenzer
Kathryn A. Robinson
Johanna L.M. Stengel
Christian A. Zang~
Class of 1956
Mary Joe Robl, BSP '52
Todd H. Stephens, BSP '93~
Chengchen Zhang
Curtis A. Bowen, BSP
Charmaine Rochester
Patricia Stewart
Julie Magno Zito~
Jerome L. Fine, BSP
John Roskos Jr., MS '56
Abigail M. Strawberry, BSP '93*
Barry Rothberg
James P. Struntz Sr., BSP '61~
Robert F. Royce, BSP '51*
Kim Sullivan
Juan-David Rueda, MS '16,
Thomas J. Sullivan
Class of 1948
Charles Summerlin, PharmD '19
Gene G. Zepp, BSP
PharmD '17
PhD '19
PharmD '99
PharmD '01
Julian M. Friedman, BSP DONORS BY CLASS YEAR
Jack Frieman, BSP Charles J. Kokoski, PhD John Roskos Jr., MS Class of 1957
Soumi Saha, PharmD '07
Peter Swaan
Tracy M. Salaam, PharmD '02
Pat Swain
Class of 1950
Donald B. Elliott, BSP
Kristina San Juan
John H. Sybert, BSP '94
Herbert Friedman, BSP
Lee H. Gradman, BSP
I. N. Sanders
Seyed E. Tabibi, PhD '82~
Andrew R. Sandler
Liza N. Takiya, PharmD '97~
Class of 1951
Bernard P. Heyman, BSP
Elizabeth Sanford
Charles D. Taylor Jr., BSP '67,
Marvin J. Chertkoff, BSP
Norman L. Levin, BSP
Amanda Schartel
David G. Danziger, BSP
Donald R. Young, BSP
Chad Scheuerell
Himali Thakkar, PharmD '13
William M. Heller, MS
Christie H. Scheuerell, MS '16
Danny R. Timney, PharmD '02
Charles J. Kokoski, BSP
Class of 1958
Teresa A. Schweiger, BSP '94
Milton F. Toelle, BSP '55*
Marvin S. Platt, BSP
Clarence L. Anstine, BSP
Morton J. Sclar, BSP '60
Patricia Torano
Robert F. Royce, BSP
Conrad Peter Dorn Jr., BSP
David J. Seff, BSP '55*
Deanna Tran, PharmD '11~
Leah C. Sera, PharmD '10~
Charles H. Tregoe, BSP '59*
Class of 1952
Patricia H. Gaskin, BSP
Savyasachi Shah
Matthew Tyrie
Carl Kaiser, MS
Michael B. Rodell, BSP
Kelly L. Shaner-Miller, BSP '92
Paige Tyrie
Anthony J. Petralia Sr., BSP
George C. Voxakis, BSP
Thomas S. Shelor, BSP '74*
Lori J. Ukleja, BSP '89
Mary Joe Robl, BSP
Clayton L. Warrington, BSP
Adrienne M. Shepardson,
Meltem Unal
PharmD ’00*
Carl L. Heifetz, BSP
William T. Foley Jr., BSP
Kimberly S. Updegraff, BSP '91
Class of 1953
Class of 1959
Matthew G. Shimoda,
Greg Vasas
Andrew Bartilucci, PhD
Harry E. Macks, BSP
Neal K. Vasist, PharmD '12
Norman DuBois, BSP
Sorell L. Schwartz, BSP
Tina L. Vassalotti, BSP '89
Paul Freiman, BSP
Charles H. Tregoe, BSP
PharmD '05 PharmD '84*
Soo Hyeon Shin, PhD '18
* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years
+ Signifies David Stewart Associates Founding Member = Signifies Deceased
sp ring 2 0 2 0
53
HONOR ROLL OF DONORS
Class of 1960
Class of 1966
Andrew Glorioso, BSP
Glenda S. Owens, BSP
Martin D. Grebow, BSP
Barry L. Bloom, BSP
Michael E. Jones, BSP
Christopher L. Shawyer, BSP
Joseph G. Handelman, BSP
Michael J. Cohen, BSP
Linda C. Klein, BSP
Larry E. Small, MS
Lois T. Havranek, BSP
Melvin Lessing, BSP
Arthur N. Riley, MS
John C. Smith, BSP
Leonard Horwits, BSP
Lawrence L. Martin, BSP
Stonewall C. King, MS
Francis J. Tinney, PhD
Joseph H. Lerner, BSP
Kenneth P. Whittemore Jr., BSP Class of 1973 Lawrence Aiken, BSP
Class of 1977
Morton J. Sclar, BSP
Class of 1967
Stephen P. Boykin, BSP
Donna M. Barrett, BSP
Larry A. Snyder, BSP
Alvin M. Blitz, BSP
Arnold E. Clayman, BSP
Katherine P. Benderev, BSP
Stephen L. Buckner, BSP
David A. Custer, BSP
Margaret C. Brophy, BSP
Charles D. Taylor Jr., BSP
Hedy J. Cylus Gleiman, BSP
Marian L. Cascio, BSP
Class of 1961 James P. Struntz Sr., BSP Irvin Yospa, BSP Class of 1962
Charles R. Downs, BSP
Leslie D. Frank, BSP
Class of 1968
Michael J. Evanko Jr., BSP
Wendy Klein-Schwartz, PharmD
Robert W. Adams, BSP
Barry D. Hecht, BSP
Raymond C. Love, PharmD
Yale H. Caplan, PhD
James P. Tristani, BSP
Denise Lupo Lutz, BSP
Ellen H. Yankellow, BSP
Judith Wenzel Smith, BSP
Stephen J. Gandel, BSP Michael J. Kopcho, MS
Class of 1969
Stephen L. Lauer, BSP
Thomas V. Bolling, BSP
Class of 1974
Class of 1978
Walter P. Mackay, BSP
G. Lawrence Hogue, BSP
Sherry N. Berlin, BSP
Stephen J. Allen, MS
Arvin P. Shroff, PhD
Julie E. Limric, BSP
Florence F. K. Gee, BSP
Howard K. Besner, BSP
Nancy L. Taylor, BSP
John M. Motsko Jr., BSP
Walter J. Hryszko, BSP
Elaine L. Brogan, BSP
Donald W. Taylor, BSP
Philip M. Perry, BSP
Susan Cohen-Pessah, BSP
Thomas S. Petr, BSP
Robert J. Davis Sr., PharmD
Class of 1963 Ingrid R. Baramki, MS
Class of 1970
Bonnie L. Pitt, BSP
Mark G. Fletcher, BSP
William H. Batt, BSP
Dennis M. Ackerman, BSP
Thomas S. Shelor, BSP
Ronald E. Lay, BSP
Yale H. Caplan, BSP
Stanley Caplan, BSP
William V. Zappa, BSP
Colleen C. Lehmann, BSP
Robert W. Henderson, BSP
Dana S. Corn, BSP
Ronald M. Hopkins, BSP
Jack H. Freedman, BSP
Class of 1975
Doris M. Peng, MS
Thomas H. Keller Jr., BSP
David H. Jones, BSP
Kirk N. Alexander, BSP
Bruce D. Roffe, MS
Henry M. Levi, BSP
Dorothy Levi, BSP
Stephen M. Gerardi, BSP
Jeffrey B. Sherr, BSP
Joseph Pariser, BSP
Michael Luzuriaga, BSP
Gregory P. Honshul, BSP
Joanne H. Sherr, BSP
Budne C. Reinke, BSP
Arthur N. Riley, BSP
Clarence A. Jeffers III, BSP
Charles H. Steg Jr., BSP
James R. Ritchie, BSP
Alan R. Stoff, BSP
Angela M. Kaitis, BSP
Reid A. Zimmer, BSP
George W. Swope Jr., BSP
Edward T. McCagh Jr., BSP
Class of 1979
Fred M. Weiss, BSP
Joseph M. Ruppel, BSP
Vahram Bedrossian, BSP
Class of 1964
Bonnie Levin, BSP
Richard L. Wynn, PhD
Richard L. Wynn, BSP
Katherine P. Benderev, PharmD Class of 1976
John E. Braaten, BSP
Class of 1971
John A. Beckman, BSP
Barry M. Bress, BSP
Class of 1965
Marsha E. Alvarez, BSP
Stephen P. Boykin, MS
Juliana Lee Chau, BSP
Robert P. Brauner, BSP
Angelo C. Voxakis, BSP
Lily Chua Eng, BSP
David D. Christ, BSP
George E. Groleau, BSP
Randy L. Crispin, BSP
Suzanne J. Caplan, BSP Harris L. Miller, BSP
Class of 1972
Miriam Kamanitz Hirsch, BSP
Mary Eckert DeLuca, BSP
Martin B. Mintz, BSP
Thomas S. Brenner, BSP
Paul F. Jarosinski, BSP
Ira L. Fedder, PharmD
Deborah G. Carroll, BSP
Daniel F. Mackley, BSP
J. Philip Fink, BSP
54
c a p su l e
www.pharmacy.umaryland.edu
HONOR ROLL OF DONORS
Bruce M. Gordon, BSP
Charise S. Kasser, BSP
Class of 1988
Class of 1992
Frederick J. Mack, BSP
Madeline McCarren, PhD
Phyllis A. Bernard, BSP
Freddy E. Banks, BSP
Gary J. Wirth, BSP
Cristina V. Platon, BSP
Michael A. Burns, BSP
Lynette R. Bradley-Baker, BSP
Magaly Rodriguez de Bittner,
Catherine L. Cioffi, PhD
Jennifer L. Carroll, BSP
Class of 1980
PharmD
Tamara Howard, BSP
Nicholas Cornias, BSP
Roberta L. Brown, PharmD
Molrat Sripinyo, BSP
Susan A. Katz, BSP
Omolola O. Elliott, BSP
Lisa T. Kloch, BSP
Hawyee T. Yan, BSP
Lisa M. Matson, BSP
Jeffrey J. Harnsberger, BSP
Stephen C. Kloch, BSP
Kimberly M. Palasik, BSP
Lori A. Hollis, PharmD
Ann G. Mantelmacher, BSP
Class of 1984
Raymond A. Palasik, BSP
Nelson E. Kline, BSP
Kevin F. McCarthy, BSP
Robin L. Becker, BSP
Nina H. Spiller, PharmD
Lisa C. LeGette, BSP
Larry E. Small, PhD
Joseph A. Demino, BSP
Wayne D. VanWie, BSP
Neil B. Leikach, BSP
Mary-Therese Hewins, MS
Fran Weiskopf, PharmD
Kelly L. Shaner-Miller, BSP
Class of 1981
Edmond J. Kucharski, BSP
Caroline T. Bader, BSP
Mark H. Lapouraille, BSP
Class of 1989
Jia-Bei Wang, PhD
Nancy A. Dravis, BSP
Carolyn S. Mason, BSP
Laurine A. Barrow-Wilson, BSP
Brenda K. Weller, BSP
Mark G. Fletcher, MS
Elizabeth S. Murias, BSP
Jennifer T. Bui, PharmD
Ilene Harris, BSP
Matthew G. Shimoda, PharmD
Natalie D. Eddington, PhD
Class of 1993
Mary-Therese Hewins, BSP
Suzanne K. Simala, BSP
Earl A. McLaren, BSP
Karla D. Evans, BSP
Hyung J. Na, BSP
Jill R. Fetter, BSP
Gary H. Magnus, BSP
Kara J. Sink, BSP
Jill R. Molofsky, BSP
Class of 1985
Barbara B. Nussbaum, BSP
Diana P. Henzel, BSP
Brian L. Schumer, BSP
Pamela E. Deiss, BSP
Luann Orehek Reno, BSP
Alice H. Hill, PharmD
Craig K. Svensson, PharmD
Daniel A. Diggins Jr., BSP
James R. Salmons, BSP
Nigel Roger Isaacs, PharmD
Joseph D. Ober, PharmD
Lori J. Ukleja, BSP
Calvin H. Knowlton, PhD
Thomas J. Pfaff, BSP
Tina L. Vassalotti, BSP
Ivy I. Laryea-Akogyeram, BSP
Andrea B. Weiss, BSP
Thomas L. Morgan, BSP
Class of 1982 Huong T. Bui Dang, BSP James M. Crable, BSP
Class of 1986
Loc K. Dang, BSP
Lauretta A. Kerr, BSP
Class of 1990
Todd H. Stephens, BSP
Leslie D. Frank, PhD
Mary Lynn McPherson, PharmD
Cindy Q. Jiang, BSP
Abigail M. Strawberry, BSP
Stephen S. Friedman, BSP
Dominique N. Phelps, BSP
Hee S. Kim, BSP
Yunga Vercelline, BSP
Bruce M. Gordon, PharmD
Keith S. Pozanek, BSP
David J. McCaffrey III, BSP
Ronald P. Kleiman, BSP
Lisa A. Shipley, PhD
Paul J. Na, BSP
Class of 1994
Lori Ann Mears, BSP
Frances Spaven, PhD
Dora M. Ober, PharmD
Kimberly Anne Compton, BSP
Janet L. Mighty, BSP
Loreen A. Wutoh, BSP
Eleanor A. O'Rangers, PharmD
Brian J. Goetz, PharmD
Lisa Coppolo Ruppel, PharmD
Susan E. Jordan, BSP
Thanh T. Tran, BSP
Teresa A. Schweiger, BSP
Seyed E. Tabibi, PhD Class of 1987
Shelby D. Reed, BSP
Class of 1983
Forest S. Howell, BSP
Stephanie L. Agelopas, BSP
Kathrin C. Kucharski, PharmD
Class of 1991
Renan A. Bonnel, PharmD
Thomas P. LaMartina, BSP
Susan M. Evans, BSP
Class of 1995
Terry L. Davis, BSP
Steven J. Miller, MS
Gayle C. Howell, BSP
Bethany A. DiPaula, PharmD
Patricia E. Draper, BSP
Mary E. Ortiz, BSP
Matthew E. McGovern, BSP
John T. Jordan Jr., PharmD
Mark G. Fletcher, PhD
Laura E. Sampson, BSP
Sara K. Meyers-Clark, BSP
Angela M. Parker, BSP
Donald J. Glenn, BSP
Mona L. Tsoukleris, PharmD
Kimberly S. Updegraff, BSP
Tracy R. Travers, BSP
Mary Therese Gyi, BSP
Donna E. VanWie, BSP
John H. Sybert, BSP
Monica L. White, PharmD
Ilene Harris, PharmD Karen M. Kabat, MS
sp ring 2 0 2 0
55
HONOR ROLL OF DONORS
Class of 1996
Michelle L. Eby, PharmD
Sangeeta V. Raje, PhD
Bryan P. Prazak, PharmD
Marshall E. Alvarez, PharmD
Lisa M. Johnson-Pope, PharmD
Tracy M. Salaam, PharmD
Kimberly Raines-Isler, PhD
Cynthia J. Boyle, PharmD
Julie A. Kreyenbuhl, PhD
Danny R. Timney, PharmD
Edward A. Taylor, PharmD
Jerome L. Fine, PharmD
Maura P. Murphy, PhD
Heather A. Nizer, PharmD
Julie Preis, PharmD
Class of 2003
George C. Voxakis, PharmD
Shelby D. Reed, PhD
Leslie J. Burgess, PharmD
Ellen H. Yankellow, PharmD
Cheryl Simmons-Gray, PharmD
David P. Cline, PhD
Class of 2007
Cheryl Fahlman, PhD
Christopher M. Blanchette, PhD
Class of 1997
Class of 2000
Lawrence J. Kotey, PharmD
Daniel C. Lyons, PharmD
Clement O. Akogyeram, PharmD
Jung Akiyama, PharmD
Carolyn Petralia, PharmD
Soumi Saha, PharmD
Charles R. Bonapace, PharmD
Theophilus E. Awuah, PharmD
Mark W. Sellers, PharmD
Nicole J. Brandt, PharmD
Jason F. Chancey, PharmD
James L. Bresette, PharmD
Maria A. Giannas, PharmD
Class of 2004
Fernando Andrickson, PharmD
Barbara S. Chong, PharmD
Suneel Kudaravalli, PharmD
Alan W. Anthony, PharmD
Yndiana Tineo Andrickson,
Sharon I. Early, PharmD
Kaysha R. Lancaster, PharmD
Calvin Y. Lee, PharmD
PharmD
Anthony A. Guerra, PharmD
Cherokee L. Layson-Wolf,
Sharon K. Park, PharmD
Ramesh Dandu, PhD
William Knebel, PharmD
PharmD
Adams O. Solola, PharmD
Stephanie Hale, PharmD
Gina Patrice McKnight-Smith,
Howard L. Robinson Jr., PharmD
Kaitlyn M. Solola, PharmD
Mojdeh Heavner, PharmD
PharmD
Thomas H. Root, PharmD
Junling Wang, MS
Erika L. Kammer, PharmD
Gisele M. Sidbury, PharmD
Michael J. Steinberg, PharmD
Kathryn M. Strong, PharmD
Charles D. Taylor Jr., PharmD
Class of 2005
Clifford W. Mason, PhD
Liza N. Takiya, PharmD
William Yeboah, PharmD
Cordelia N. Abazie, PharmD
Melike G. Tunc, PharmD
Terri A. Thompson Cathers,
Zeynep T. Tunc, PharmD Thomas G. Williams Jr., PharmD
Class of 2008
Kathleen Klemm, PharmD
Surabhi Y. Dangi-Garimella, PhD Class of 2001
Devon M. Flynn, PharmD
Class of 2009
Michael G. Beatrice, PhD
Tushar S. Garimella, PhD
Dongyi Du, PhD
Class of 1998
Becky A. Briesacher, PhD
Jeanine E. Jackson, PharmD
Erin S. Dudley, PharmD
Thomas J. Biles, PharmD
Daniel A. Farney, PharmD
Rachna Kapoor, PharmD
Arley Hunter, PharmD
Jeffrey M. Brewer, PharmD
Tamara Howard, PharmD
Kristine Rapan Parbuoni, PharmD
Louis M. Jones, PharmD
Jae Hyung Carpenter, PharmD
Yelee Y. Kim, PharmD
Adrienne M. Shepardson,
Michelle M. Ceng, PharmD
Kan Chan Ku, PharmD
PharmD
Class of 2010
Harold Chappelear, LLD (Hon)
Chidubem N. Nwankwo, PharmD
Junling Wang, PhD
Denise Fu, PharmD
Terry L. Davis, PharmD
Lois A. Reynolds, PharmD
Patrick Y. Kamara, PharmD
Pritesh K. Shah, PharmD
Class of 2006
Whitney N. Hanson, PharmD
Jonathan N. Latham, PharmD
Kathleen J. Sremcich, PharmD
Omoniyi A. Agunbiade, PharmD
Rana Rais, PhD
Robin L. Paluskievicz, PharmD
Charles T. Wells III, PharmD
Linda W. Canady, PharmD
Leah C. Sera, PharmD
Denise P. Toyer-McKan, PharmD
Bay-Mao B. Wu, PharmD
Mary Therese Gyi, PharmD
PharmD
David M. Yoder, PharmD
Yara K. Haddad, PharmD
Brian M. Hose, PharmD
Class of 2011
Class of 2002
Helen Hsiao, PharmD
William C. Charles, PharmD
Class of 1999
Anthony M. Ishak, PharmD
Angel N. Jordan, PharmD
Tatiana Claro da Silva, PhD
Abimbola O. Adebowale, PhD
Tali M. Johnson, PharmD
Angela M. Kaitis, PharmD
Alicia M. Gronseth, PharmD
Lynette Bradley-Baker, PhD
Trinh Michelle Keelin, PharmD
Lawrence J. Krebs, PharmD
Siyun Liao, PharmD
Patrick K. Brannen, PharmD
Hellen N. Kiruthi, PharmD
Daniel Z. Mansour, PharmD
Rachel L. Melnick, PharmD
Susan C. dosReis, PhD
Yoon-Hee C. Lee, PharmD
Kellie M. Monzillo, PharmD
Kathleen M. Morneau, PharmD
Charles R. Downs, PharmD
Yvonne K. Molotsi, PharmD
Deborah J. Pippin, PharmD
Steven B. Shannon, PharmD
56
c a p su l e
www.pharmacy.umaryland.edu
HONOR ROLL OF DONORS
Matthew O. Siuta, PharmD
Arinzechukwu P. Nwanokwai,
Jan Sieluk, PhD
Affiliates
Sheryl E. Thedford, PharmD
PharmD
Joseph E. Vandigo, PhD
$10,000-$24,999
Deanna Tran, PharmD
Naitia M. Nwatu, PharmD
Anthony O. Uwadia, PharmD
Pamela N. Roberto, MS
Class of 2019
James C. Wang, PharmD
Stephanie E. Shulder, PharmD
Andrew Chayasriwong, PharmD
American Foundation for
American Association of Colleges of Pharmacy
Meagan C. Small, PhD
Ryan Costantino, MS
Class of 2012
Joseph E. Vandigo, MS
Odera I. Ekwunife, PharmD
Samuel Waxman Cancer
Joy Y. Chai, PharmD
Emily S. Wiener, PharmD
Ankit Gandhi, PharmD
Katherine E. Nelson, PharmD
Candice Yong, PhD
Teny Joseph, PharmD
Teledyne Hanson Research
Sai C. Nimmagadda, PharmD
Pharmaceutical Education Research Foundation
Juan-David Rueda, PhD
Jingjing Qian, PhD
Class of 2016
Charles Summerlin, PharmD
Sponsors
Neal K. Vasist, PharmD
Husam A. Albarmawi, MS
Andrew Wherley, PharmD
$1,000-$9,999
Alice A. Williams, PharmD
Lauren Barbour, PharmD
Abbott Laboratories
Dianna L. Campbell, PharmD
Albertsons
Class of 2013
Nicole Caprio, PharmD
GIVING BY CORPORATIONS
ASHP Foundation
Jennifer A. Abernathy, PharmD
Brittany C. Couto, PharmD
AND FOUNDATIONS
Baltimore Community
Nichole D. Althouse, PharmD
Jasmine M. Ebron, PharmD
Youjin Chang, PharmD
Priyanka Gaitonde, MS
Patrons
CVS Health Foundation
Hansong Chen, PharmD
Geoffrey A. Heinzl, PhD
$100,000 +
Equashield, LLC
Frances A. Gray, PharmD
Dianna N. Kenner-Staves,
Alpha-1 Foundation
Exxon Mobil Foundation
Nachi A. Mbinkar, PharmD
PharmD
Cystic Fibrosis Foundation
Fidelity Charitable Gift Fund
Jeffrey S. Mrowczynski, PharmD
Andongfac Nkobena, PharmD
Laura and John Arnold
FLAVORx
Andrew V. Phan, PharmD
Ihuoma U. Onyewuchi, PharmD
Foundation
Hereford Pharmacy, Inc.
Tye D. Souders, PharmD
Juan-David Rueda, MS
Merck & Co. Inc.
Huseyin Tunc Memorial Fund, Inc.
Himali Thakkar, PharmD
Christie H. Scheuerell, MS
International Society for Benefactors
Pharmacoeconomics &
Class of 2017
$50,000-$99,999
Outcomes Research
Jackie Tran, PharmD Mingxiang Wang, PharmD
Foundation
Eric E. Daniels, MS
Academy of Managed Care
Northern Pharmacy & Medical
Class of 2014
Robyn E. Firmin, PharmD
Pharmacy
Equipment
Laura M. Bozzi, MS
Melissa G. Fiscus, PharmD
MedStar Health
SilcsBio, LLC
Jennifer A. Cho, PharmD
Frederick M. Hindman, PharmD
Pharmaceutical Research and
UMSOP Class of 2017
John P. Dolan, PharmD
Yoon Duk Hong, PharmD
Walgreens
Erin P. Freeman, PharmD
Jonathan A. Meyer, PharmD
Society of Infectious Diseases
Manufacturers of America
Waters Corp.
Kwabena O. Nimarko, PharmD
Pharmacists
Class of 2015
Ha K. Phan, PharmD
Springer Science + Business
Contributors up to $999
Mary Afrane, PharmD
Kumaran Ramakrishnan, PharmD
Media LLC-NJ
AB&J RX Corp.
Viktor Chirikov, MS, PhD
Alpha Zeta Omega Kappa
Terrence Clemmons, MS
Class of 2018
Associates
Chapter
Christopher W. Dobroth, PharmD
Priyanka Gaitonde, PhD
$25,000-$49,999
Brookneal Drug Co.
Beatrice A. Kallungal, MS
Lena Kim, PharmD
Making a Difference in Infectious
Cape St. Claire Volunteer Fire Co.
Aida E. Kuzucan, PharmD
Joey Mattingly, PhD
Diseases
Catonsville Pharmacy
Alexandra L. McPherson, PharmD
Elisabeth Oehrlein, PhD
Fibus Drug Store
Barbrakaryne N. Nchinda Fobi,
Soo Hyeon Shin, PhD
Finksburg Pharmacy
PharmD
sp ring 2 0 2 0
57
HONOR ROLL OF DONORS
Gilchrist Hospice Care
GIFTS OF TRIBUTE
Good Shepherd Preschool
This is a listing of gifts received from July 1, 2017, to June 30, 2018. We have made every effort to provide
Jarrettsville Pharmacy
The School of Pharmacy
a complete and accurate listing of donors and
Levin & Gann, P.A.
received gifts of tribute for the
gifts. If we have made an error or omission, please
Network for Good
individuals listed below:
accept our sincere apology and contact the Office of
Seasons Hospice and
In Honor Of:
Development and Alumni Affairs at 410-706-5893 or
Harold Chappelear, LLD (Hon)
ggriffith@rx.umaryland.edu so that we may correct
C. Daniel Mullins, PhD
our records.
Palliative Care
SNC Partners LLC The Pfizer Foundation, Inc. Wedgwood Club
In Memory Of: Yvette A. Beakes, PharmD Dennis E. Ferguson, BSP Aaron Grebow, BSP Dean Ellis Leavitt, BSP, MS Brylene S. Schwartz Huseyin C. Tunc, BSP Herbert C. Wagner, BSP Bernard A. Weisman, BSP Thomas G. Williams Sr., PharmD Martin W. Wolff Jr., PhD.
58
c a p su l e
www.pharmacy.umaryland.edu
When you make a gift to the School’s Annual Fund… Your gift counts as a vote of confidence, demonstrating your support for the University of Maryland School of Pharmacy. Unrestricted gifts provide a crucial bridge between tuition revenue and the actual cost of operations, offering budgetary relief and directly affecting students, faculty, and numerous programs across the School. Most importantly, unrestricted gifts — regardless of the size — allow the dean to respond to the School’s most pressing financial concerns and provide flexibility to seize unique and important opportunities that advance practice, science, research, pharmapreneurship, and community service.
Unrestricted gifts to the University of Maryland School of Pharmacy’s Annual Fund help: › Strengthen financial aid programs, which defray the cost of tuition and expenses › Ensure that facilities are kept in excellent condition › Fund important faculty research initiatives › Support the operating budget › Provide flexibility to meet the School’s changing needs › Allow for the retention and expansion of our world-class faculty
Please consider making your Annual Fund gift today by visiting www.pharmacy.umaryland.edu/go/give or by making a check out to the University of Maryland Baltimore Foundation, Inc. and placing it in the envelope provided within this issue of Capsule.
A Gift That Keeps on Giving More than half of School of Pharmacy students rely on scholarships, fellowships, and financial aid to make their dream of becoming a pharmacist or researcher a reality. As a student in the School’s Pharmapreneurship Pathway within the PharmD program, president of the University’s Entrepreneurship and Innovation Network, and a finalist in the School’s annual “America’s Got Regulatory Science Talent” competition, Jordan Fraker embodies all of the qualities of a strong pharmapreneur. As such, she was named the inaugural recipient of the Felix A. KhinMaung-Gyi Memorial Scholarship for Pharmapreneurship, the largest scholarship in the School’s history, which provides one full year of tuition.
In the journey to develop a new idea or product, we as entrepreneurs become accustomed to failure and quickly learn that we must be our own source of encouragement,” she says. “Receiving recognition from others through awards and scholarships such as the Felix A. KhinMaung-Gyi Memorial Scholarship goes beyond encouragement. It reinforces my work and gives me a sense of comfort that I am on the right path and that others believe in my endeavors. I am incredibly grateful to the Gyi family for their support. — Jordan Fraker Third-Year Student Pharmacist
Please contact Ken Boyden, JD, EdD, associate dean for development and alumni affairs, at kboyden@ rx.umaryland.edu or 410-706-3816 to create an endowed scholarship to benefit the next generation of pharmacists and researchers.
60
c a p su l e
www.pharmacy.umaryland.edu
MESSAGE FROM DEVELOPMENT
Ken Boyden
Be thoughtful. Be smart. Bequest. Include a gift to the University of Maryland School of Pharmacy in your will. At the University of Maryland School of Pharmacy, we are working hard to push the boundaries of education, research, practice, and service, putting ideas into action and harnessing the School’s potential to improve lives in our classrooms, our labs, our clinics, our communities, and around the world. For years, bequests have benefited all aspects of the School, supporting everything from scholarships and fellowships, to research, to programs that spark innovation and shape the future of health care. No matter your passion, when you include the School in your will, you enhance the areas that you care about in a meaningful way. Charitable bequests can be a great way to give back because they are easy to establish, cost you nothing today, and are 100 percent free of federal estate taxes. Choosing to remember the University of Maryland School of Pharmacy with a gift in your will is a wise and thoughtful way to fuel the School’s power of expertise, influence, and impact. Contact us for bequest language specific to your giving situation. Your estate gift also will entitle you to membership in the School’s Legacy Council — our way of thanking you for your impactful generosity.
Thank you for your ongoing support.
Ken Boyden, JD, EdD Associate Dean Office of Development and Alumni Affairs 410-706-4415 kboyden@rx.umaryland.edu
Nonprofit Organization U.S. Postage
PAID Permit No. 4695
20 N. Pine Street Baltimore, MD 21201-1180
Baltimore, Maryland
Connect on RxIntersect! We invite you to check out RxIntersect, our online networking platform that ensures every University of Maryland School of Pharmacy student and alumnus has the professional connections needed to succeed. We know that finding a job can be daunting, so making the most of your connections is important. To give you a leg up, we recently have added a job board where alumni can see and post jobs. Through RxIntersect, you can virtually connect and network with more than 6,000 alumni, students, and faculty from the School of Pharmacy. It’s a convenient and efficient way to: } Share experiences } Exchange career advice } Build professional networks based on interests and career tracks
} Search for jobs within your field
Visit rxintersect.umaryland.edu to participate. Click “Join the Community” to register with either your LinkedIn account or an email address.